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ABSTRACT 
     
            The objectives of this study were the isolation, identification, 
examination of antibiotic sensitivity and comparing the size of plasmids 
DNA of Escherichia coli.  
            A total of one hundred and ninety samples were collected from 
Khartoum State from infected poultry tissues, calf fecal samples, mastitic 
cow’s milk, women urine, bovine abscesses, and child diarrhea. 
          E.coli was isolated from infected poultry tissues (81 %), calf fecal 
sample (60 %), mastitic cow’s milk (60 %), women urine (53.3 %), bovine 
abscess (20) %, and child diarrhea (66.7%). 
          Twelve antibiotics were examined. All isolates were highly sensitive 
for amikacin (99%), ceftizoxim (99%), cephalexin (95%), nitrofuranation 
(95%), gentamicin (89%), ampicillin (85%), chloramphenicol (73%), 
ciprofloxacin (78%), norfloxacin (78%), ofloxacin (78%). The isolates were 
resistant to tetracycline (78%) and nalidixic acid (58%). Amoxicillin (61%) 
and pefoxacin (73%) were medium sensitive. 
            The infected poultry isolates were completely sensitive to amikacin 
(100%) and ceftizoxim (100%), while child diarrheal isolates were 
completely sensitive to cephalexin (100%), nitrofuranation (100%), nalidixic 
acid (100%) and ofloxacin (100%). Also women urine isolates were 
completely sensitive to amikacin (100%), ceftizoxim (100%), 
chloramphenicol (100%), nitrofuranation (100%) and pefloxacin (100%). 
            Mastitic cow’s milk isolates were completely sensitive to all 
antibiotics (100%) except amikacin and tetracycline showed some resistance 
(67%). 
          Calf fecal isolates were completely sensitive to all antibiotics (100%) 
except amoxicillin, tetracycline, ciprofloxacin, nalidixic acid and 
norfloxacin. 
            Bovine abscess isolates were completely sensitive to all antibiotics 
(100%) except amoxicillin, tetracycline, nalidixic acid, ofloxacin showed 
high resistance (100%), while ciprofloxacin and norfloxacin showed 
intermediate susceptibility (50%). 
            Multi- drug resistance was shown by most of the E.coli strains 
isolated in this study. The multiple drug resistance observed varied from two 
drugs multiple resistance (tetracycline- nalidixic acid) to nine drugs multiple 
resistance (cephalexin, gentamicin, ampicillin, amoxicillin, 
chloramphenicol, ciprofloxacin, norfloxacin, ofloxacin, and pefoxacin). 
          E.coli strains showed the highest multiple drugs resistance were 
isolated from infected poultry tissues (up to 9 antimicrobial drugs) women 
urine (up to 7 antimicrobial drugs) and bovine abscess (up to 6 antimicrobial 
drugs). 
          Most of the strains showed multi- resistance; 75.7% of isolates were 
resistant to at least two antibiotics, 59.8% were resistant to at least three 
antibiotics, 43.1% were resistant to at least four antibiotics, 25.7% were 
resistant to at least five antibiotics and 18.9%  were resistant to at least six 
antibiotics.   
          The isolates did not showed clear bands of plasmid for unseen reason. 
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        INTRODUCTION 
 
          Escherichia coli usually abbreviated to E. coli, discovered by Theodor 
Escherich, a German pediatrician and bacteriologist, is one of the main 
species of bacteria that live in the lower intestines of mammals. E. coli is the 
type species of the genus Escherichia, which contains mostly motile gram-
negative bacilli within the family Enterobacteriaceae and the tribe 
Escherichia. The bacteria are necessary for the proper digestion of food and 
are part of the intestinal flora. E. coli can be the causative agent of several 
intestinal and extra-intestinal infections such as urinary tract infections, 
meningitis, peritonitis, mastitis, septicemia and Gram-negative pneumonia. 
The enteric E. coli are divided on the basis of virulence properties into 
enterotoxigenic (ETEC, causative agent of diarrhea in humans, pigs, sheep, 
goats, cattle, dogs and horses), enteropathogenic (EPEC, causative agent of 
diarrhea in humans, rabbits, dogs, cats and horses), enteroinvasive (EIEC, 
found only in humans), verotoxigenic (VTEC, found in pigs, cattle, dogs and 
cats), enterohaemorragic (EHEC, found in humans, cattle and goats), 
attaching-effacing (AEEC, collects E. coli found among EPEC in humans, 
EHEC in humans, cattle and goats, and porcine strains that colonize the gut 
in a manner similar to human EPEC strains) and enteroaggregative E. coli 
(EAggEC, found only in humans). Appropriate treatment depends on the 
disease and should be guided by laboratory analysis of the antibiotic 
sensitivities of the infecting strain of E. coli. Antibiotics which may be used 
to treat E. coli infection include (but are not limited to) amoxycillin, 
trimethoprim-sulfamethoxazole, ciprofloxacin, nitrofurantoin. Antibiotic 
resistance is a growing problem. Some of this is due to misuse of antibiotics 
in humans, but some of it is probably due to the use of antibiotics as growth 
promoters in animal’s food.            
          In recent years, the management of E. coli infections has been 
increasingly complicated by the emergence of resistance to most first-line 
antimicrobial agents (James et al., 2006). Antibiotic drug- resistance is 
worldwide problem. Drug resistance is now very wide spread, and strains are 
commonly encountered that are resistant to more than one drug (Carter, 
1985). 
          After six decades of widespread antibiotic use, bacterial pathogens of 
human and animal origin are becoming increasingly resistant to many 
antimicrobial agents. Antimicrobial resistance develops through a limited 
number of mechanisms: (a) permeability changes in the bacterial cell 
wall/membrane, which restrict antimicrobial access to target sites; (b) active 
efflux of the antimicrobial from the cell; (c) mutation in the target site; (d) 
enzymatic modification or degradation of the antimicrobial; and (e) 
acquisition of alternative metabolic pathways to those inhibited by the drug 
(McDermott et al., 2003). 
          Numerous bacterial antimicrobial resistance phenotypes result from 
the acquisition of external genes that may provide resistance to an entire 
class of antimicrobials. These genes are frequently associated with large 
transferable extrachromosomal DNA elements called plasmids, on which 
may be other mobile DNA elements such as transposons and integrand. An 
array of different resistance genes may accumulate on a single mobile 
element, presenting a situation in which multiple antibiotic resistance can be 
acquired via a single genetic event. The versatility of bacterial populations in 
adapting to toxic environments, along with their facilities in exchanging 
DNA, signifies that antibiotic resistance is an inevitable biological 
phenomenon that will likely continue to be a chronic problem. Successful 
management of current antimicrobials, and the continued development of 
new ones, is vital to protecting human and animal health against bacterial 
pathogens (McDermott et al., 2003). 
          This study is carried out to isolate E.coli from different sources, 
investigate the prevalence of antibiotic resistance to different antimicrobial 
agents and compare the size of plasmids DNA of E.coli isolates having 
different multi- resistance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
1                       LITERATURE REVIEW 
 
1.1 Historical background  
         Escherichia coli commonly called E. coli, is just one of many bacteria 
that can cause diarrhea. The first isolation of E. coli was mode by a young 
Austrian Pediatrician, Dr. Theodor Escherich in Munich 1885. He was 
holding clinical assistantships at children’s Polyclinic and Hunters children    
s Hospital; he carried out researches in the intestinal flora of children as a 
possible cause of epidemics of diarrhea. The name of the Bacterium coli 
commune was read for the first time, which is now known as B. coli. He 
became the leading bacteriologist in the field of pediatrics and an authority 
on infant nutrition (Tortura et al., 1986). 
        In animal the ability of E. coli to cause diarrhea was first suggested in 
late 1800 and early 1900 by several veterinary workers studying the calves 
scours ( Nocard and Lectainche, 1898 ; Joest , 1903 : Titze and Orcut, 1908 . 
       The organism was isolated along with other bacteria from the faeces of 
newborn babies. It was found to be concomitant with breastfeeding. 
Escherich described it as a short plump rod, growing readily on gelatin or 
agar. On potato and coagulated milk, it grew as a slimy mass with the 
production of acid. In the early days different names have been applied to 
the organism such as Bacillus escherichii in 1889, Bacillus coli in 1895. In 
1900 it was known variously as Bacterium verus, Bacillus coli communes 
and Aerobacter coli. The genus Escherichia was first proposed by Migula in 
1895 and became firmly established in 1919 by castellani and charmers in 
the third edition of the Manual of Tropical Medicine (Tortura et al., 1986). 
          Bray (1945) investigated and outbreak of enteritis in London hospital 
and showed that aparticular serological type of E. coli was the epidemic 
agent. In the same year certain strains of E. coli were isolated from children 
5 – 8 years of age with diarrhea at school in London. Workers found that 
these strains invade the epithelial cells and cause diarrhea. 
          The pathogenicty of E. coli was firstly suggested by laurelle in 1889. 
In the past three types of E. coli were recognized Enterotoxigenic E. coli, 
Enteropathogenic E. coli, Enteroinvasive E. coli (Lambert, 1979). 
         At present eight types of E. coli are recognized Enterotoxigenic E. coli, 
Enteropathogenic E. coli, Enteroinvasive E. coli, Enteroaggregative E. coli, 
Diffuselly adhering E. coli, Uropathogenic E. coli, Enterohaemorrhagic E. 
coli and E. coli that causes sepsis and meningitis . 
1.2 Classification of Escherichia  
          The genus Escherichia belongs to family enterobacteriaceae (Barrow 
and Feltham, 1993). 
The enterobacteriaceae includes the following tribes: 
1- Eschericheae. 
2- Klebsielleae. 
3- Proteusae. 
4- Yersinieae. 
5- Erwineae.  
The tribe Eschericheae includes five genera: 
1- Escherichia. 
2- Edwardsiella. 
3- Citrobacter. 
4- Salmonella. 
5- Shiglla.    
The genus includes the following species: 
1- E.coli : 
          Like many other enterobacteria contains numerous serotypes some of    
which are associated with certain infections in man and animals, some are 
particularly associated with diarrheal disease while others causes avareity of 
extra intestinal infections (Orskov and Orskov,1976). 
2- E.adecarboxylata: 
          It was described by Leclerc (1962), stranes were isolated from clinical 
specimens. 
3- E.fergusonii : 
          It was proposed by Farmer et al. (1985). It was isolated from animal 
and human clinical materials. 
4- E.hermanii : 
          It was isolated particularly from wounds. It was described by Brenner 
et al. (1982). 
5- E.blattae : 
          It was isolated from the intestinal tract of cockroaches and has not 
been reported in clinical material (Barrow and Feltham, 1993). 
6- E.vulneris : 
          It was also described by Brenner et al. (1982) as anew species to 
include group of strains, many of which were isolated from human wounds. 
1.3 Definition of E.coli  
          Escherichia coli are a straight Gram negative rod and nonsporing rod. 
It grows readily on simple nutrient media, occurring singly or in pairs. Most 
of the organisms are motile with peritrichus flagella. The total number of 
serotypes is very high (Bergey’s Manual of Systematic Bacteriology, 1984). 
The organism is a normal inhabitant of the lower part of the intestinal tract 
of all warm-blooded animals. Usually t is not found in the intestines of fish 
or other cold-blooded animals. A few numbers or none are found in the 
stomach and anterior portion of the bowel. It is found in greater abundance 
in carnivores and omnivores than herbivores (Gillespie and Timoney, 1981). 
Being a primary components of faeces, it is therefore one of the most 
ubiquitous bacteria on the surface of the earth (Sojka, 1965). Frequently 
there are very few numbers of the bacteria in the faeces of cows and horses. 
Most are harmless saprophytes but others are virulent pathogens that affect 
the intestine and extra intestinal sites. The major diseases caused by E.coli 
are enteric infections, septicemia, urinary tract infection, and mastitis. Under 
certain condition the numbers of these organisms undergo a marked and 
rapid increase in vivo, and this may be associated with definite signs of 
illness and some times death (Buxton and Frazer, 1977). It is aerobic and 
facultatively anaerobic.     
1.4 Normal habitat of E.coli 
          E.coli is a world wide in distribution. Many E.coli are part of normal 
flora of the intestinal tract of human and animal. Some species are free 
living occurring in soil, water and vegetation (Carter, 1985). E.coli becomes 
established in the intestine shortly after birth when the sterile intestine of the 
fetus is seeded with bacteria derived from the mother and the environment. 
E.coli passes easily and reaches the intestine because in newborn animal and 
human the stomach pH is nearly neutral. E.coli continues throughout adult 
live as the intestine and is usually the dominant isolate on aerobic culture of 
feaces or intestinal contents. Most strains of E.coli are harmless commensals 
but others are virulent pathogens that affect intestine or extra- intestinal sites 
(Gyles, 1993). 
1.5 Characteristics of E.coli  
 1.5.1 Morphology  
         Escherichia coli is straight rods measuring 1.1-1.5 by 2.0-6.0µm 
(living) or 0.4 - 0.7 by 1.0 - 3.0 µm (dried and stained) with parallel sides 
and rounded ends. It is a Gram-negative rod, that may form chains under 
unfavorable condition (exposure to penicillin) capsules or microcapsules are 
produced by many stains. The organism is non acid fast and non – spore 
former (Jon, 1984).  
         Many strains possess peritrichous flagella but may be sluggish motile, 
some strains are non-motile or only feebly motile. The organism stain Gram- 
negative (Buxton and Frazer, 1977). 
1.5.2 Capsules     
     Certain strains of E.coli that cause diarrhea in calves and a subset of 
strains that cause diarrhea in pigs produce abundant capsular 
polysaccharide that may aid in colonization of the intestine (Hadad and 
Gyles, 1982). The polysaccharide capsule is produced in vivo and appears 
to be a virulence factor in these strains. Spontaneous a capsular mutant of 
these strains failed to colonize the intestine and to produce diarrhea in 
experimental infected calves (Hadad and Gyles, 1982). It is uncertain, 
however, whether the acapsular mutants were deficient in structures 
and/or products other than capsular polysaccharide. Studies on the ultra 
structure of the capsulated E.coli in association with the intestine of 
calves suggest that the bacteria attached to the intestinal epithelium 
(Hadad and Gyles, 1982; Acres, 1985).     
 
1.5.3 Cultural characteristics 
          The organism is aerobic and facultative an aerobic in the presence of a 
fermentable carbohydrate. Growth occur between 14-45ºc (optimum 
temperature is 37ºc). Optimum pH for growth is 7 but growth occurs within 
a wide pH range. It grows readily on ordinary laboratory media. Uniform 
clouding is produce in broth after 12-18 hours incubation. Colonies on 
nutrient agar have slightly raised surfaces. Pigments are not produced. 
Growth on agar slants is in confluent with a turbid water of syneresis. Wide 
zones of beta type of haemolysis around colonies are produced by some 
strains. Colonies on agar medium are usually 2-3 mm in diameter (Bale et 
al., 1984).  
1.6 Isolation and cultural characterization of E.coli 
1.6.1 Media for isolation of E.coli 
            Three types of media can be used for primary isolation of E.coli: 
1.6.1.1 Differential or selective media 
        A- MacConkey’s agar media 
              It is used to detect coli form and enteric pathogens from faecal 
samples based on their ability to ferment lactose. Lactose fermenting 
bacterial species like E.coli gives pink to red colinies while other non lactose 
fermenting organisms give coluorless to transparent colonies after an 
overnight incubation at 37ºc on this medium. 
       B- Eosin and methylen blue medium (EMB) 
                It is used for the isolation of lactose fermenting Gram negative 
organism like E.coli. Eosin and, methylen blue medium consist of peptone 
base with lactose, sucrose, eosin and methylen blue. Eosin and methylen 
blue serve as indicators for fermentation as well as inhibiting gram-positive 
organisms. 
           On EMB media E.coli like lactose fermenting organisms produces a 
black precipitate. Colonies will be either black or posses dark center with 
transparent colourless peripheries after an overnight incubation at 37ºc. 
1.6.1.2 Enrich medium 
       Blood agar is used for first isolation for E.coli from systemic infection. 
Blood agar is constituted of tryptose, sodium chloride, heart infusion, agar 
and 5% sheep blood. 
        E.coli is an aerobe and facultative anaerobe. On blood agar E.coli 
produce (1-4) mm in diameter colonies after an overnight incubation at 37ºc. 
The colonies may appear mucoid and some strains are haemolytic due to 
production of haemolysin. 
1.6.1.3 Basic media  
        Nutrient agar is used for sub culturing of E.coli from differential 
selective or storage media(slant) prior to perform biochemical and 
serological identification(Monica, 2000). 
1.6.1.4 Maintenance and preservation of E.coli   
         E.coli can survive well in holding media as modified Carey-Blair 
medium for several weeks to month without losing its plasmids (Sack, 
1981). 
        Storage of strains in liquid broth media supplemented with 15% 
glycerol as cryopreservative at -70ºc gives good stability of the enterotoxin 
properties as well as of the surface adhesion. Storage of strains on Dorset 
egg medium at 4ºc is a good alternative for liquid broth media. 
Lypholization of E.coli strains also give a good stability of plasmid for years 
(Sack, 1981).       
 
1.7 Resistance to physical and chemical agents  
          E.coli is relatively susceptible to physical and chemical agents. In the 
majority of instances a temperature of 55ºc for one hour or 60ºc for 20 
minutes is lethal to these organisms. They are killed rapidly by autoclaving 
at 120 º c.Under natural conditions; E.coli may survive for weeks or months 
in water, faeces and dust in animal houses. They are highly susceptible to the 
lethal action of phenol and cresol, but the efficacy of these disinfectants is 
reduced in the presence of mucus and faeces (Buxon and Frazer, 1977). 
1.8 Biochemical tests 
          Biochemical tests for the differentiation of E.coli from other closely 
related bacterial groups must be based on the reactions which occur in a 
variety of media. All strains of E.coli ferment glucose and lactose with the 
production of acid and gas (Buxton and Frazer, 1977), but few strains are 
late lactose fermenters or may often fail to ferment this sugar (Sojka, 1965). 
Buxton and Frazer (1977) stated that the majority of strains ferment 
mannitol, form indole but fail to produce H2S and do not grow on citrate 
medium, and it dose not produce gelatinase enzyme, Most strains do not 
develop urease, give a negative voges-proskaur reaction and are positive to 
the methyl red test. 
          Milk is coagulated and acidified. Faecal E.coli is able to grow in 
MacConkey’s lactose bile broth at 44ºc (Ejkman’s test) with the production 
of gas. This test is of value for water bacteriologists in presumptive 
identification of faecal E.coli. Generally, there is no single biochemical 
feature which is particularly characteristic of Escherichia group. A 
comparison of various reactions is required for its classification (Robertson 
and Maclowry, 1974). 
1.9 Antigens and toxins 
          The complex O, H and K antigenic structure of E.coli have been 
studied in detail because they form the basis on which the serotypes can be 
differentiated one another (Buxon and Frazer, 1977). 
1.9.1 O antigens                  
          These are the somatic antigens occurring as part of the bacterial body 
and composed of a polysaccharide phospholipids protein complex (Buxon 
and Frazer, 1977). 
1.9.2 K antigens 
          These antigens which occur as envelops or capsules on most strains of 
E.coli, are composed of polysaccharides. The K antigens show different 
degrees of thermoability which are the basis for subdividing them into L, A 
and B varieties (Buxon and Frazer, 1977). 
1.9.3 H antigens             
          These are the flagellar antigens which are composed of protein. 
Passage of the strain through semi-solid medium often results in increased 
development of H antigen and of motility. (Buxon and Frazer, 1977) 
1.9.4 Fimbrial antigens  
          Fimbriae occur as small filaments situated over the whole surface of a 
bacterium. Fimbriae are antigenic, and their antigens are not specific for 
bacterial serotypes or for groups. Repeated sub-culturing of fimbriated 
bacteria on solid media may result in the loss of fimbriae. Growth in fluid 
media encourages their development. 
          Bacteria possessing fimbriae agglutinated red blood cells of various 
animal species and man. This form of haemagglutination reaction is due to 
the adherence of fimbriae to the surface of red blood cells (Buxon and 
Frazer, 1977). 
1.9.5 Common antigens (CA) 
          Some serotypes develop another somatic antigen in addition to the O 
antigen referred to above. It appears to be common to many members of 
different bacterial groups, it is composed of polysaccharide (Buxoon and 
Frazer, 1977). 
1.10 Classification of pathogenic E.coli  
          Pathogenic E.coli differs from the non-pathogenic E.coli by the 
presence of virulence factors organized in clusters in the chromosome or 
plasmid. According to the large variation in DNA content and to the 
difference in the distribution of genomic location (insertion site) of different 
virulence determinants, pathogenic E.coli were divided into eight major 
categories(Puente and Finlay, 2001). 
1.10.1 Entero-toxigenic E.coli (ETEC) 
          ETEC cause watery diarrhea, ranging in severity from mild and self-
limiting to severe cholera-like profuse diarrhea (Sack, 1975).  
1.10.1.1 Prevalence of the disease caused by ETEC 
          In human all ages are susceptible to the disease, the disease is less 
common in breast fed infant. During the weaning the disease is common 
(Guerrant et al., 1975).In adult the disease usually affects the travelers 
(Black, 1990).          
          In calves the disease is restricted to those under 4 months of age 
(Holland, 1990).  
1.10.2 Enteroinvasive E.coli (EIEC)                                                                     
          Enteroinvasive E.coli (EIEC) were characterized by their positive 
reaction in the Sereny test, in which strains are tested for their ability to 
cause keratoconjunctivitis in guinea pig eyes. This is a characteristic which 
EIEC share with strains of Shigella (Ephros et al., 1996). 
1.10.2.1 Virulence factors of EIEC   
          EIEC secretes invasion plasmid antigens (Ipas) A-D for invasion of 
the host cell (colonic epithelium) (Kocks et al., 1995). 
1.10.3 Enteropathogenic E.coli (EPEC)   
      It is the predominant cause of infant diarrhea world wide and affects 
children under 6 years (Levine and Edelman, 1984).  
1.10.3.1 Virulence factors of EPEC 
          EPEC in order to develop lesion it requires three stages. First stage is 
characterized by the initial non intimate attachment to epithelial cell surface 
in a pattern termed localized adherence (L.A) (Giron et al., 1991). During 
the second stage a set of EPEC secreted proteins (ESPs) leading to a 
complex response by the epithelial cell, and during the third stage and outer 
membrane protein called intimin allows EPEC to attach intimately to the 
host cell membrane on interaction with its translocated intimin receptor  
called “tir” (Lia et al., 1997).  
1.10.4 Enterohaemorrhagic or verotoxigenic E.coli (EHEC)  
        It causes bloody watery diarrhea, abdominal pain, fever and vomiting. 
In severe cases it leads to heamolytic anemia (Brunder et al., 1997). 
1.10.4.1 Virulence factors of EHEC     
         For EHEI to cause disease three major virulence attribute, the capacity 
to causes formation of attaching and effacing lesions (A/B) (Brunder, 1999). 
1.10.5 Enteroaggregative E.coli (EAEC)       
          Enteroaggregative adherence demonstrated by enteroaggregative 
E.coli (EAggEC) consists in the bacteria aligning themselves in parallel 
rows to their tissue cells or glass. These EAggEC are mainly associated with 
persistent childhood diarrhea in Brazil, Chile, Mexico and India (Cobeljic et 
al., 1996). 
1.10.5.1 Virulence factors of EAEC   
          EAEC strains adhere to cultured cells in small clumps or aggregates 
through aggregative adherence fimbriae (AAFıand AAFıı). EAEC strains 
produce two types of enterotoxin (Eslava et al., 1998). 
1.10.6 Diffusely adhering E.coli (DAEC) 
          Diffuse-adhering Escherichia coli (DAEC) strains were significantly 
associated with persistent watery diarrhea in children between 2-5 years 
(Giron et al., 1991). 
1.10.6.1 Virulence factors of DAEC 
          DAEC has been associated with four different adhesions while toxins 
have not been described (Peiffer et al., 1998). 
1.10.7 Uropathogenic E.coli (UPEC) 
          It causes urinary tract infections (UTI) (Jose et al., 2002). 
1.10.7.1 Virulence factors of UPEC 
          In order to successfully colonize and establish urinary tract infection, 
UPEC encode several adhesion, both are fimbrial or non-fimbrial adhesion 
(afimbrial adhesion Afa-І and Afa-Ш) (Johnson, 1991). 
1.10.8 E.coli that causes neonatal sepsis and meningitis  
          In addition to gasterointestinal and urinary tract infection, some strains 
of E.coli can cause septic (invasive) diseases in newborn (Quagliarello and 
Scheld 1992). 
1.10.8.1 Virulence factors 
          E.coli that causes septic diseases produces a polysaccharide capsule 
that blocks complement and antibody deposition on the bacterial surface and 
thus avoid uptake and clearance by antibody-mediated immune events 
(Roins et al., 1974). E.coli that causes meningitis and sepsis often produces 
type-1 pili. (Korhonen et al., 1985). 
1.11 Enterotoxin 
          Enterotoxin is a common cause of diarrhea in animal (Buxton and 
Frazer, 1977) and infants in developing countries (Jawetz et al., 1995). They 
are divided according to their heat stability and their mechanism of action 
into: Heat-labile (LT) enterotoxin and Heat-stable (ST) enterotoxin. 
1.12 Mode of Transmission 
          Transmission of E.colithrough ingestion of contaminated food, water, 
milk,and vegetables. Infection by E.coli require large dose 10 9 cfu of 
bacteria to be ingested or inoculated (Lambert, 1979).  
1.13 Epidemiology and pathology 
          Pathogenic strains of E.coli are associated with diseases of the 
intestine, septicemias of newborn or young animals and with respiratory 
tract disease of poultry. The disease is characteristically found in newborn or 
young animals and a variety of epidemiological factors can be involved. 
Moreover etiological agents other than E.coli can be present at the same 
time. A critical factor is the immune status of the newborn animals. 
          ETEC is an under recognized but extremely important cause of 
diarrhea in the developing world where there is inadequate clean water and 
poor sanitation and also the most common cause of traveler’s diarrhea. 
ETEC diarrhea is most frequently seen in children, suggesting that a 
protective immune response occurs with age (Qadri et al., 2005).     
1.14 E.coli infection in animals and man  
          The organism produce colibacillosis in all species of newborn farm 
animals, it is a major cause of loss in this age group (Blood et al., 1990). 
Infection also occurs in man and poultry with various maninfestation. 
 
1.14.1 Cattle  
1.14.1.1 Colibacillosis  
          Diarrhea in newborn calves under 10 days of age is one of the most 
common diseases. It may cause intestinal and extra intestinal infections 
(Salvadori et al., 2003). It is a major cause of economical losses in cattle 
herds. The treatment and control of neonatal diarrhea in calves have been 
difficult.There are three different types of the disease. 
І enteric colibacillosis   
          This is manifested mainly by varying degrees of diarrhea. 
Π septicemic colibacillosis 
          This is manifested by septicemia and rapid death. Occur only in very 
young calves. Colostrum provides protection against coli septicemia in 
calves but does not prevent diarrhea.  
Ш Enterotoxic colibacillosis  
          Enterotoxic colibacillosis characterized byenteric toxemia. Diarrhea is 
usually not evident in spite of the slightly distended abdomen (Blood et al., 
1990). 
          All breeds of beet and diary calves are affected. Out breaks are more 
common in case of intensive livestock rearing. In small herds, the disease 
occurs only sporadically during calving season (Gillespe and Timoney, 
1981). Isolation of the organism from the internal organs of an aborted 
bovine fetus was reported by Moorthy (1985). 
1.14.1.2 Mastitis 
          Bovine mastitis due to E.coli, Klebsiella, or Enterobacter is referred to 
as coliform mastitis and may occur as a peracute, acute, chronic, or 
subclinical infection (Nemeth, 1992). E.coli is by for the most important of 
the Gram negative environmental organisms that cause mastitis in diary 
cattle. Anonymous 1977 reported mastitis after inoculation of E.coli into the 
mammary gland of healthy cows. Bacteria in the environment invade via the 
teat canal and establish a local infection that is confined to the udder. 
          No markers have been identified to distinguish strains of E.coli that 
cause mastitis from strains in normal faeces and the environment. E.coli 
 recovered from the udders of cattle with mastitis belong to a wide range of 
O serogroups and exhibit biochemical properties indistinguishable from 
those of E.coli from the faeces and environment (Nemeth, 1987). Although 
capsule and serum resistance have been suggested to be virulence factors for 
mastitic E.coli, those E.coli that cause bovine mastitis appear to be simply 
opportunistic environmental organisms that have no special virulence 
factors.  
          The antibacterial proprieties of milk, the un availability of free iron in 
milk, and the levels of specific opsonins in milk undoubtedly function in 
defense against infection in the mammary gland. Polymorph nuclear 
leukocytes constitute the major antibacterial defense against bacteria 
invading the mammary gland and effectively phagocytes and destroy 
bacteria opsonized by IgM (Nemeth, 1987) has been implicated in necrosis 
of the superficial layer.        
1.14.2 Sheep  
          Some cases of colibacilosis in lambs develop enteric signs but the 
majority of cases are septicemic and per acute. Tow age groups are affected 
lambs 1-2 days old and lambs 3-8 weeks old. Per acute cases are found dead 
without showing any signs. Acute cases are characterized by collapse, 
occasionally signs of meningitis, followed by recumbency (Blood et al., 
1990). 
       Lambs with enteric colibacillosis develop diarrhea, depression which 
may be followed by death. Less severe symptoms include meningitis and 
arthritis (Gillespie and Timoney, 1981). Abortion attributed to E.coli 
infection was reported by Howarth (1932).  
1.14.3 Goats  
          Muller (1960) reproduced sterility in female goats when served by 
males infected with E.coli haemolytic strains. The organism was the only 
pathogen recovered from 34 diarrheic goats by rectal swabs over a period of 
one year in India. Serogroups O24, O28, O45, O54, O61, O121, O138, and 
O148 were identified (Osmani et al., 1992). 
1.15.4 Camels 
          An endemic E.coli infection in new born camels was reported by 
Romboli (1942). It resembled neonatal septicaemia in other farm animals. 
The most common manifestation of the intestinal form of the disease was 
diarrhea. Chauhan and Kaushik (1991) isolated enterotoxigenic E.coli from 
camels with diarrhea.  
1.14.5 Horses  
          Buxom and Frazer (1977) suggested that newborn foals can suffer 
from a disease which may be associated with a variety of bacteria including 
E.coli, abortion and metritis had been reported in mares (Dimock et al., 
1947). 
1.14.6 Pigs 
          Hagan and Burner (1988) mentioned that distinct manifestations of 
enteric colibacillosis were seen in swine include neonatel E.coli enteritis, 
enteritis shortly after wearning and odema disease in various body tissue of 
pigs soon after weaning. E.coli also had been shown to be a cause of acute 
meningitis and fibrinous poly serositis in piglets (wilkie, 1981). 
1.14.7 Dogs  
           E.coli, particularly the haemolytic strains, have been associated with 
acute generalized infections in puppies and with either intestinal or 
urogenital infections in older animals including pyometra and occasionally 
cystitis (Buxton and Frazer, 1977). Haemorrhagic gastro-enteritis was 
reported in puppies up to 4 weeks of age. The disease was characterized by 
haemorrhagic gastro-enteritis, congestion of the lungs and hearts. Meningitis 
and haemorrhages covering the whole carcasses were also observed (Mansi, 
1962).  
          Sinior et al. (1992) recovered 82 E.coli isolates from dogs with 
urinary tract infections. E.coli is the most frequent cause of (UTI) urinary 
tract infection in dogs and cats (Oxendford et al., 1984).  
1.14.8 Cats  
          Experimental E.coli infection was reported in 5-8 months old cats by 
IIIyutovich et al. (1962). The cats were fed orally E.coli serotype O111:H12. 
Enteritis was developed in 2-6 days after administration. The test organism 
was isolated on the second day after dosing and continued to be excreted in 
the faeces until the 57th day. 
1.14.9 Avian pathogenic E.coli (APEC)  
        E.coli adversely affects avian species through infection of the blood, 
respiratory tract, and soft tissues. Disease resulting from E.coli infections, 
such as colibacillosis air sacculitis and cellulites, cause high morbidity and 
mortality in poultry, which have a significant economic impact on the 
poultry industry (Bass et al.,1999). Avian colibacillosis is complex 
syndrome characterized by multiple organ lesions with air sacculitis and 
associated pericarditis, perihepatitis and peritonitis being most typical. More 
than 20(APEC) strains have been investigated in animal experiments (Ewers 
et al., 2003). 
       Like most pathogenic E.coli, avian isolates can not be distinguished 
biochemically from the normal common sales inhibiting the gastrointestinal 
tract of birds. Using a molecular approach we were able to identify genetic 
difference among avian E.coli isolates by restriction fragment length poly 
morphism (RFLP) and random amplification of poly morphic DNA (RAPD) 
by the polymerase chain reaction (PCR) (Maurer et al., 1998).  
         Cellulites derived strains presented phenotypic and genotypic 
characteristic of greater virulence than did the fecal isolates from healthy 
chickens (De Brito et al., 2003). 
         The organism causes the following disease when it spread via the 
circulatory system: 
1.14.9.1 Acute septicemia  
          Synonyms coli septicaemia, colibacillosis, E.coli infection, septic 
pericarditis, and air sacculitis (Sokia and Carnaghan.1961).This disease is a 
major threat to broiler production with an increasing incidence due to 
increased intensive production. Growing chickens and turkeys are affected. 
Broiler chickens 6-10 weeks old are being more susceptible. The most 
common serotypes causing the disease are O1: KI (L), O2:K1 (L) and O78: 
k80 (B) (Hostad et al., 1978).  
1.15.9.2 Embryo and early chick mortality 
          In chicks up to 3 weeks of age, the yolk sac is the predilection site of 
infection (Gordon and Jordan, 1982). Infections occurs as a result of 
contamination of eggs, whether from faeces or from infection of the ovary of 
the hen. Affected chicks develop omphalitis and mushy-yolk disease 
(Cheville and Arp, 1978). The condition was reproduced following air-sac 
injection with E.coli serogroup O78 (Sasipreeyajan and Pakpinyo, 1992).  
1.14.9.3 Respiratory tract infection (air sac disease)  
          Five to twelve weeks old chickens and particularly broilers are 
affected. Inhalation of contaminated dust is the main route of transmission. 
The air sacs are thickened and there is often a caseous exudates on the 
respiratory surfaces (Cheville and Arp, 1978). 
1.14.9.4 Synovitis 
          Young birds of all species are affected. Knee, elbow, shoulder, hock 
and foot joints are affected mostly. They may be thickened and swollen 
causing severe lameness. The organism may spread to other organs 
including kidneys, pectoral muscles and bone marrow (Gordon and Jordan, 
1982). 
1.14.9.5 Panophthalmitis   
          Usually one eye is affected. It becomes blind as a result of hypopyon 
and destruction of the retina (Hofestad et al., 1978). 
1.14.9.6 Coligranuloma (Hjarre’s disease)  
          This is characterized by coli granuloma of Turkeys. The spleen may 
be affected. Well developed lesion resembles a tubercular granuloma 
(Hoftad et al., 1978). 
1.14.9.7 Enteritis  
          Affected birds exhibit weakness, inappetance, diarrhea and cyanosis 
of the wattles. Lesions include petechial hemorrhagic in the intestines, heart, 
lungs and kidneys. The liver is enlarged (Nagi and Khana, 1967). 
 
 
 
1.14.9.8 Pericarditis            
          Pericardial tissue appears to be the predilection site for septicaemic 
E.coli strains. Pericaditis may be associated with perihepatitis (Borstein and 
Samberg, 1953) omphalitis or respiratory disease. 
1.14.10 Human  
 1.14.10.1 Childhood Diarrhea  
          Diarrhea is a leading cause of morbidity and mortality among children 
in developing countries. The bacterial pathogen most commonly associated 
with endemic forms of childhood diarrhea is Escherichia coli. At least six 
categories of diarrheagenic E.coli have been described: enteropathogenic 
E.coli (EPEC), enterotoxigenic E.coli (ETEC), enteroinvasive E.coli (EIEC), 
enterohemorrhagic E.coli (EHEC), enteroaggregative E.coli (EAEC) and 
diffusely adherent E.coli (DAEC). Two additional categories cell detaching 
E.coli (CDEC) and cytolethal distending toxin producing E.coli (CLDTEC), 
have been proposed. The epidemiological significance of each E.coli 
category in childhood varies with geographical area. 
          Epidemiological evidence and human challenge studies have 
demonstrated unequivocally that EPEC, ETEC, EIEC and EHEC are 
important causes of diarrhea world wide (Okeke et al., 2000). 
1.14.10.2 E.coli O157:H7   
          E.coli o157:H7 is a common cause of a variety of illnesses including 
bloody diarrhea and the hemolytic uremic syndrome (HUS). The O157:H7 
serotype was first described in the literature in 1983 following two outbreaks 
of hemorrhagic colitis in a fast-food restaurant chain in Organ and Michigan 
in 1982. The most frequent mode of transmission for E.coli 
O157:H7infections is through consumption of contaminated food and water, 
and several outbreaks have been caused by ground beef. Approximately 1% 
of healthy cattle may have the organism in their intestines (Arne lindsted et 
al., 2003).  
1.14.10.3 Urinary tract infection (UTI)    
      Urinary tract infections are common clinical entities occurring in a 
variety of patient groups, most frequently caused by uropathogenic E.coli 
(Stapleton, 2003). 
1.15 Antibiotics 
1.15.1 Definition  
          An organism protects itself from enemies in various ways. It may 
produce metabolic waste products, which change the condition in medium, 
such as pH, osmotic pressure and surface tension making the environment 
unfavorable to the growth of less tolerant organisms. It may elaborate 
specific toxic substances, which interfere with the metabolism of other 
organism to such an extent that they are either killed or prevented from 
multiplying. These specific toxic substance are called antibiotics 
(Salle, 1971). Heritage et al. (1996) defined an Antibiotic as a substance that 
was produced by microorganism that in very low concentration inhibits or 
kills the growth of another microorganism. 
1.15.2 Classification and mechanism of action  
          Since antibiotics were first discovered in the 1920s, much knowledge 
has been acquired on their mode of action and the significance of this action 
on their relative merits in the therapy of man and animals. 
          Antibacterial agents can be divided into four groups as they affect the 
synthesis of nucleic acid, protein, the formation of the cell wall and 
permeability of cell membrane. 
 
 
1.15.2.1 Nucleic acid inhibitors 
          Replication of the nucleic acids of the bacterial cell is prevented 
directly by nalidixic acid and rifamycin and indirectly by the sulphonamides. 
Sulphonamides ultimately deprive the cell of nucleic acid and the presence 
of nalidixic acid prevents its replication. 
          Sulphonamides are structural analogues of para-amino benzoic acid 
PABA and competitively inhibit an enzymatic step (dihydropteroate 
synthase) during which PABA in incorporate in the synthesis is reduced, the 
levels of tetrahydropholate (folinic acid). Because dihydropteroate synthesis 
is reduced, the levels of tetradihydropteroate (folinic acid) formed from the  
dihydropteroate diminishes. Tetrahydropholate is an essential component of 
the coenzymes responsible for single carbon metabolism in cells. Acting as 
antimetabolites to PABA, sulphonamides eventually block, in a complex 
fashion, several enzymes. These enzymes include those needed for the 
biogenesis of methionine, glycine and formymethionyl-transfer RNA. These 
results in suppression of protein synthesis impairment of metabolic 
processes and inhibition of growth and multiplication of those organisms 
that can not use preformed folate. The effect is bacteriostatic, although a 
bactericidal action is evident at high concentration that may occur in urine 
(Aiello and Mays, 1998).  
          Quinolones inhibited bacterial DNA gyrases (Topoisomerases) which 
was catalyzed supercoiling of bacterial DNA (Thomas, 1993). 
          Nalidixic acid inhibits DNA synthesis without affecting RNA 
synthesis and is employed mainly for urinary infections caused by Gram-
negative bacteria (Carter, 1985). 
 
 
1.15.2.2 Protein synthesis inhibitors  
          Antibiotic classes that act by inhibiting protein synthesis include 
aminoglycoside e.g. gentamicin, tobramycin, kanamycin and streptomycin, 
tetracycline, chloramphenicol, macrolides, e.g erythromycin and 
azithromycin, and lincosamides, e.g clindamycin (Forbes et al., 1998; 
Cheesbrough, 2000). 
          Aminoglycosides inhibit bacterial protein synthesis by binding to 
protein receptors on the organism’s 30S ribosomal subunit. This process 
interrupts several steps, including initial formation of the protein synthesis 
complex, accurate reading of the mRNA code, and disruption of the 
ribosomal- mRNA complex (Baker and Breach, 1980; Forbes et al., 1998). 
          Macrolides (erythromycin and azithromycin) bind to the 50S subunit 
of the ribosome and the binding site is a 23S rRNA (Jawetz et al., 1998). 
          Chloramphenicol inhibits the addition of new amino acids to the 
growing peptide chain by binding to the 50S ribosomal subunit (Jawetz et 
al., 1998). This antibiotic is highly active against a variety of Gram- 
negative and Gram- positive bacteria (Forbes et al., 1998). 
          Tetracyclines inhibit protein synthesis by binding to the 30S 
ribosomal subunit so that incoming tRNA- amino acid complexes cannot 
bind to the ribosome, thus halting peptide chain elongated. Tetracyclines 
have a broad spectrum of activity that includes Gram- negative bacteria, 
Gram- positive bacteria, and several intracellular bacterial pathogens such as 
Chlamydia and rickettsia (Jawetz et al., 1989;Forbes et al.,1998). 
          Lincosamides (clindamycin) inhibited protein synthesis by binding to 
receptors on the bacterial 50S ribosomal subunit and subsequent disruption 
of the growing peptide chain. Primarily because of uptake difficulties 
associated with Gram- negative outer membrane, the macrolides and 
clindamycin generally are not effective against most genera of Gram- 
negative bacteria. However, they are effective against Gram- positive 
bacteria (Forbes et al., 1998). 
1.15.2.3 Cell wall synthesis inhibitors 
          The bacterial cell wall known as the peptidoglycan, or murein layer, 
plays an essential role in the life of the bacterial cell. The cell wall of 
bacteria is tough and rigid and lies external to the cell membrane, giving the 
whole cell protection from possible osmotic damage (Forbes et al., 1998). 
Several agents affect cell wall synthesis, the most important being penicillins 
e.g. cloxacillin, ampicillin and amoxicillin, cephalosporins e.g. cephradine, 
cefuroxime and ceftazidime and glycopeptide e.g. vancomycin 
(Cheesbrough, 2000). 
          Beta- lactam antimicrobial agents are those that contain the four- 
membered, nitrogen- containing, beta lactam ring at the core of their 
structure, and mode of action of these drugs that target and inhibit cell wall 
synthesis by binding the enzymes involved in synthesis. The beta-lactam 
antibiotics inhibit the last step in peptidoglycan synthesis, the final 
crosslinking between peptide side chain, mediated by bacterial 
carboxypeptidase and transpeptidase enzymes (Forbes et al., 1998). 
          Glycopeptides which are the other major class of antibiotic that inhibit 
bacterial cell wall synthesis, e.g. vancomycin is the most commonly used 
agent in this class inhibits cell wall synthesis by binding to precursors of cell 
wall synthesis (Forbes et al., 1998). Vancomycin can not penetrate the outer 
membrane of most Gram- negative bacteria to reach their cell wall precursor 
targets, because of its relatively large size. There fore, this agent is usually 
ineffective against Gram- negative bacteria (Forbes et al., 1998). 
          Some fungi of cephalosporium spp yield antimicrobial substances 
called cephalosporins (Jawetz et al., 1989). Cephalosporins consisted of 
three generations first one was cephradine and cephalothin, second was 
cefuroxime and third were ceftazidime and cefotaxime ((Jawetz et al., 1989; 
Cheesbrough, 2000). 
          The mechanism of action of cephalosporins is analogous to that of 
penicillins by binding to specific PBPs that serve as drug receptors on 
bacteria; inhibiting cell wall synthesis by blocking the transpeptidation of 
peptidoglycan; and activating autolytic enzymes in the cell wall that can 
produce lesions resulting in bacterial death (Jawetz et al., 1989). 
1.15.2.4 Cell membrane function inhibitors  
          Polymyxins (polymyxin B and colistin) are the agents most commonly 
used that disrupt bacterial cell membranes. Most notably, they are more 
active against Gram- negative bacteria, while activity against Gram- positive 
bacteria tends to be poor (Forbes et al., 1998). Polymyxin becomes firmly 
bound to the cytoplasmic membrane and acts by damaging this structure 
(Thomas, 1993). 
1.15.3 Toxicity and side effects  
          Not all antimicrobial, at the concentration required to be effective are 
completely non- toxic to human cells. Most, however, show sufficient 
selective toxicity to be of value in the treatment of microbial disease 
(Cheesbrough, 2000). Most serious side effects of penicillin are due to 
hypersensitivity. The tetracycline and chloramphenicol produce varyng 
degrees of gastrointestinal upset (nausea, vomiting, and diarrhea). 
          Gentamicin was toxic, particulary in the presence of impaired renal 
function. Fever, skin rashes and other allergic manifestation may result from 
hypersensitivity to streptomycin (Jawetz et al., 1989). 
1.15.4 Antibiotic spectrum  
 1.15.4.1 Broad spectrum antibiotics 
          The term broad spectrum is applied to antibacterial agents with 
activity against a wide range of Gram- positive and Gram- negative 
organisms such as tetracyclines, aminoglycosides, sulphonamides and 
chloramphenicol (Thomas, 1993; Cheesbrough, 2000). 
1.15.4.2 Narrow spectrum antibiotics  
          Narrow spectrum antibiotics are those with activity against one or few 
types of bacteria, e.g. vancomycin against staphylococci and enterococci 
(Cheesbrough, 2000). 
1.15.5 Type of action  
          Antimicrobial agents are generally described as bacteristatic when, at 
usual dosage, they prevent the active multiplication of bacteria, e.g. 
chloramphenicol, tetracycline and erythromycin, and are described as 
bactericidal when, at usual dosage, they kill bacteria, e.g. the penicillins, 
cephalosporins, glycopeptides and aminoglycosides (Cheesbrough, 2000). 
          Some bacteristatic agents become bactericidal when used at higher 
concentration e.g. erythromycin and tetracycline (Thomas, 1993; 
Cheesbrough, 2000). 
1.15.6 Clinical use of antibiotics  
          The object of antibiotic therapy is to cure the patient with the 
minimum of complications and discomfort. At the same time, it is important 
to discourage the emergence of drug- resistant organisms. The principles 
should observed are, antibiotics should not be given for trivial infections 
they should be used for prophylaxis only in special circumstances, treatment 
should be based on a clear clinical and bacteriological diagnosis, the choice 
of antibiotic is essentially a clinical matter. Antibiotics for systemic 
treatment should be given in full therapeutic doses for an adequate period. In 
local treatment of superficial infections it is important to use antiseptics 
which are rarely or never used systematically, e.g. mupirocin, bacitracin and 
polymyxin. Antibiotic solutions and powders should not be liberated into the 
environment. They can cause hypersensitivity reactions and encourage 
development of antibiotic- resistant strains (Thomas, 1993). 
1.16 Drug Resistant 
          If bacteria are repeatedly subcultured in the presence of gradually 
increasing subinhibitory concentration of an antibiotic it is usually possible 
to obtain mutant organisms which will survive and multiply in concentration 
which are lethal for the parent strain (Thomas, 1993). 
          Antibiotics can be inactivated either by enzymatic cleavage or by 
chemical modification such that they no longer interact with the target site or 
are no longer taken up by the organism rendering them inactivates (Pratt, 
1990; Lancini, 1995). 
          The development of antibiotic- resistant strains during therapy was 
unlikely to be a serious clinical problem because the fraction of resistant 
cells in bacterial population was always very small (Davies, 1994). 
          Drug resistant has increased substantially in recent years and has 
reduced the value of formerly widely prescribed agents such as the 
sulphonamides and ampicillin (Hugo and Russell, 1989).  
1.16.1 Multidrug resistance  
          Often bacterial isolates are multidrug resistant; however the vast 
majority of studies have looked at the detection and diagnosis of resistance 
caused by one class of antimicrobial agents while others have looked at the 
detection of resistance to multiple antimicrobial agents (Fluit et al., 2001).                    
Resistant enterobacteriaceae frequently contain multiple plasmids, the larger 
of which can carry genes for resistance to 10 or more antimicrobial agents 
(Jacoby, 1991). These highly resistant bacteria were made many currently 
available antimicrobial drugs ineffective and in certain instances were 
already posing important public health problem (Cohen, 1992).  
          Integrons are a special case of multidrug resistance. Integrons are 
genetic elements that contain the genetic determinant of a site-specific 
recombination system that recognize and captures mobile gene cassettes. An 
integron contains an integrase and an adjacent recombination site. Gene 
cassettes can be integrated by the integrase at the recombination site, and 
multiple gene cassettes can be present in one integron (Fluit et al., 2001). 
Four classes of integron have been described. Class І integrons are often 
associated with the sulfonamide resistance gene (sull) and are the most 
common integrons. Calss 2 integrons are associated with Tn 7.Only one 
class 3 integron has been described, and class 4 is limited to Vibrio chlderae. 
Integrons are found almost exlusively in Gram-negative bacteria, with one 
known exception. At least 60 gene cassettes have been described for class І 
integrons. The majority of genes encode antibiotic and disinfectant 
resistance, including resistance to amino glycosides penicillins, 
cephalosporins, trimethoprim, tetracycline, erythromycin and 
chloramphenicol (Fluit et al., 2001).  
1.16.2 Mechanisms of antibiotics resistance 
          Successful bacterial resistance to antimicrobial action requires 
interruption or disturbance of one or more of the steps essential for effective 
antimicrobial action. These disturbance or resistance mechanisms can come 
about in various ways, but the end result is partial or complete loss of 
antibiotic effectiveness. Different aspects concerning antimicrobial 
resistance mechanisms include biologic vs. clinical antimicrobial resistance, 
environmentally mediated antimicrobial resistance, and microorganism- 
mediated antimicrobial resistance (Forbes et al., 1998). 
1.16.2.1 Biologic vs. clinical resistance 
          Development of bacterial resistance to antimicrobial agents to which 
they were originally susceptible requires alterations the cell’s physiology or 
structure. Biologic resistance refers to changes that result in the organism 
being less susceptible to a particular antimicrobial agent than has been 
previously observed. When antimicrobial susceptibility has been lost to such 
an extent that the drug is no longer effective for clinical use the organism 
has achieved clinical resistance (Forbes et al., 1998). 
1.16.2.2 Environmentally mediated antimicrobial resistance 
          Environmentally mediated resistance is defined as resistance that 
directly results from physical or chemical characteristics of the environment 
that either directly alters the antimicrobial agent or alters the 
microorganism’s normal physiologic response to the drug. Examples of 
environmental factors that mediate resistance includes pH, anaerobic 
atmosphere, cation (e.g. Mg++ and Ca++) concentrations, and thymine- 
thymidine content (Forbes et al., 1998). 
1.16.2.3 Microorganism- mediated antimicrobial resistance 
          Microorganism- mediated resistance refers to antimicrobial resistance 
that is due to genetically encoded traits of the microorganism and is the type 
of resistance that in vivo susceptibility testing methods are targeted to detect 
(Forbes et al., 1998). Organism- based resistance can be divided into two 
subcategories, intrinsic or inherent resistance and acquired resistance. 
1.16.2.3.1 Intrinsic resistance  
          Intrinsic resistance is antimicrobial resistance resulting from the 
normal genetic, structural, or physiological state of microorganism  
(Forbes et al., 1998). Such resistance is considered to be natural and 
consistently inherited characteristic that is associated with the vast majority 
of strains that constitute a particular bacterial group, genus or species. There 
for, this is predictable resistance so that once the identity of the organism is 
known, so are certain aspects of its antimicrobial resistance profile (Forbes 
et al., 1998). 
1.16.2.3.2 Acquired resistance  
          Bacteria can acquired resistance to antibiotics as a result of a 
chromosomal mutation, expression of a latent chromosomal gene, by 
exchange of genetic material through transformation (the exchange of 
DNA), transduction (bacteriophage), or conjugation by plasmids 
(extrachromosomal DNA) (Neu, 1992). 
          Acquired resistant was usually reversible. However, the ease with 
which resistance reverts to sensitivity depends upon a number of factors 
such as nature of the organism, nature of the drug, degree of resistance that 
has been established, and whether the resistance has been acquired by 
genetic or phenotypic adaptation (Salle, 1971). It was antibiotic resistance 
that results from altered cellular physiology and structure caused by changes 
in microorganism’s usual genetic makeup (Forbes et al., 1998). 
          The basic mechanisms of acquired microbial resistance to 
antimicrobial agents were generally divided into five categories, the 
development of an altered drug target; a decrease in the concentration of 
drug that reaches the receptors by altered rates of entry or removal of the 
drug; degradation of the antibiotic; synthesis of resistant, or alternate 
metabolic pathways that were no longer susceptible to an antibiotic; and 
failure to metabolize the drug to its active state (Neu, 1992; Davies, 1992; 
Spartt, 1994; Brody, 1994). 
1.16.3 Common pathways for antimicrobial resistance  
          Whether resistance is intrinsic or acquired, bacteria share similar 
pathways or strategies to affect resistance to antimicrobial agents. The 
pathways involve enzymatic or alteration of the antibiotic, decreased 
intracellular uptake or accumulation of drug, and altered antibiotic target are 
the most common (Davies, 1994; Forbes et al., 1998).  
          Based on their reaction to staining protocol, bacteria were divided into 
Gram- negative and Gram- positive classifications. Gram- positive bacteria 
were surrounded by a thick, rigid, porous cell wall composed of 
peptidoglycans. It offers little resistance to the diffusion of small molecules 
such as antibiotics. Gram- negative bacteria have an additional outer 
membrane composed of lipopolysaccharide that was located around the 
cytoplasmic membrane and the thin peptidoglycan layer (Bordy, 1994).   
1.16.3.1 Resistance to β-lactam antibiotic 
          β-lactam antibiotics are among the most commonly used antimicrobial 
agents. They act on penicillin binding proteins (PBPs), which are involved in 
cell wall synthesis. Penicillin, a β-lactam antibiotic, was one of the first 
antibiotics. Resistance is most often caused by the presence of β-lactamases, 
but mutations in PBPs resulting in reduced affinity for β-lactam antibiotics 
are also commonly observed. Resistance is less frequently caused by 
reduced uptake due to changes in the cell wall or active efflux. Genes 
encoding β-lactamases can locate either on plasmids or the bacterial 
chromosome and are found among both Gram-negative and Gram-positive 
organisms (Fluit et al., 2001). 
1.16.3.2 Resistance to aminoglycosides 
          Aminoglycosides such as gentamicin, tobramycin, amikacin and 
streptomycin are commonly used antimicrobial agents in the treatment of 
infection by both Gram-negative and Gram-positive organisms. Amino 
glycosides bind to the ribosome and thus interfere with protein synthesis. 
Resistance to these antimicrobial agents is widespread, with more than 50 
amino glycoside-modifying enzymes already described. Most of these genes 
are associated with Gram-negative bacteria. Depending on their type of 
modification, these enzymes are classified as aminoglycoside 
acetyltransferases (AAC), amino glycoside adenyltransferases, also named 
amino glycoside nucleotidyltransferases (ANT), and amino glycoside 
phosphotransferases (APH). Amino glycosides modified at amino groups by 
(AAC) enzymes or at hydroxyl groups by (ANT) or (AOH) enzymes lose 
their ribosome-binding ability and thus no longer inhibit protein synthesis   
(Fluit et al., 2001).  
1.16.3.3 Resistance to fluroquinolones 
          Fluroquinolones antibiotics exert their antibacterial effects by 
inhibition of certain bacterial topoisomerase enzymes namely, DNA gyrase 
(bacterial topoisomerase Π) and (topoisoisomerase IV). These essential 
bacterial enzymes alter the topology of double-stranded DNA (ds DNA) 
within the cell. DNA gyrase and topoisomerase IV are heteroterameric 
proteins composed of two subunits, designated A and B. The genes encoding 
the A and B subunits are referred to as gyrase A and gyrase B (DNA gyrase) 
or par C and par E (DNA topoisomerase IV (grl A and grl B in S.aureus)). 
DNA gyrase is the only enzyme that can effect super coiling of DNA. 
Inhibition of this activity by fluroquinolones is associated with rapid killing 
of the bacterial cell. Topoisomerase IV is predominantly responsible for the 
separation of daughter DNA strands during cell division (Fluit et al., 2001). 
          Mechanisms of bacterial resistance to fluoroquinolones fall into two 
principal categories, alteration in drug target enzymes and alteration that 
limit the permeation of drug to the target. The target enzymes are most 
commonly altered in domains near the enzyme active site and in some cases 
reduced drug binding affinity has been demonstrated (Fluit et al., 2001). 
          In Gram-negative organisms, DNA gyrase seems to be the primary 
target for all quinolones. In Gram-positive organisms, topoisomerase IV or 
DNA gyrase is the primary target depending on the fluoroquinolone 
considered the quinolone structure determines the mode of antibacterial 
action. The primary target seems to depend on the bacterial species as well 
as on the quinolone structure (Fluit et al., 2001). 
1.16.3.4 Resistance to glycopeptides 
          Vancomycin and teicoplanin are glycopeptide antibiotics of clinical 
interest. The antimicrobial activity is due to binding to D-alanyl –D-alanine 
side chains of peptidoglycan or its precursors thereby preventing cross-
linking of the peptidoglycan chain. Antimicrobial activity of glycopeptide 
antibiotics is largely limited to Gram-negative bacteria inside the outer cell 
membrane can not be reached by the glycol peptide molecule. Not all Gram-
positive organisms are susceptible to the glycol peptide antimicrobial agents 
(Fluit et al., 2001). 
1.16.3.5 Resistance to tetracyclines 
          Tetracyclines probably penetrate bacterial cells by passive diffusion. 
Tetracycline act by binding to the 30S ribosomal subunit, resulting in the 
inhibition of protein synthesis. A growing number of bacterial species have 
acquired resistance to the bacteriostatic activity of tetracycline. At least 24 
tetracycline resistance (Tet) determinants and three oxytetracycline 
resistance (Otr) determinant (Fluit et al., 2001). 
          Most of the resistance genes code for one of the two important 
mechanisms of tetracycline resistance, either efflux or ribosomal protection. 
These two widespread mechanisms of bacterial resistance to tetracycline do 
not destroy the compound. Efflux is mediated by energy-dependent efflux 
pumps, the other important mechanism involves and elongation factor G-like 
protein that confers ribosome protection. Oxidative destruction of 
tetracycline has been found in a few species (Fluit et al., 2001). 
1.16.3.6 Resistance to trimethoprim 
          Trimethoprin is an analog of dihydrofolic acid, an essential 
component in the synthesis of amino acid and nucleotides that competitively 
inhibits the enzyme dihydrofolate reductase (DHFR). Resistance can be 
caused by a number of mechanisms including overproduction of the host 
DHFR, mutation in the structural gene for DHFR, and the acquisition of 
gene (dfr) encoding a resistant DHFR enzyme. The latter mechanism is the 
most important in clinical isolates (Fluit et al., 2001). 
          At least 15 DHFR enzyme types are known based on their properties 
and sequence homology (Fluit et al., 2001). On of the first studies which 
described the use of molecular techniques for the detection of trimethoprim 
resistance investigated the presence of type І and type Π DHFR in diverse 
Gram-negative isolates showing high levels of trimethoprim resistance (Fluit 
et al., 2001). 
1.16.3.7 Resistance to chloramphenicol 
          Chloramphenicol binds to the 50s ribosomal subunit and inhibits to 
the peptidyl transferase step in protein synthesis (Fluit et al., 2001). 
Resistance to chloramphenicol is generally due to inactivation of the 
antibiotic by a chloramphenicol acetyltransferase. The cat genes of Gram-
negative and Gram-positive bacteria show little homology, and a variety of 
different enzymes have been described. The gene is most commonly found 
on plasmids. Some times decreased outer membrane permeability or active 
efflux is observed in Gram-negative bacteria (Fluit et al., 2001). 
1.17Antibiotic sensitivity  
          Antimicrobial resistance is now recognized as an increasingly global 
problem which was observed for the first time in E.coli 1940. The primary 
factor responsible for the development and spread of bacterial resistance is 
the injudicious use of antimicrobial agents (Atif et al., 2000). 
          Antibiotic usage is considered the most important factor promoting the 
emergence, selection and dissemination of antibiotic-resistant micro 
organism in both veterinary and human medicine. Antibiotic usage selects 
for resistance not only in pathogenic bacteria but also in the endogenous 
flora of exposed individuals (animal and human) or populations (Bogaard et 
al., 2001). Antibiotics are used in animals as in human for therapy and 
control of bacterial infections. In intensively reared food animals, antibiotics 
may be administered to whole flocks rather than individual animals. In 
addition antimicrobial agents may be continuously fed to food animals such 
as broiler as antimicrobial growth promoter. There for the antibiotic 
selection pressure for resistance in bacteria in poultry is high consequently 
their faecal flora contains a relatively high proportion of resistant bacteria 
(Bogaard et al., 2001). 
          Currently, there is increased public and scientific interest in the use of 
therapeutic and sub therapeutic antimicrobials in animals. This is due 
primarily to the possible emergence and dissemination of multiple-drug-
resistant zoonotic bacterial pathogens. Antimicrobial drug-resistant bacterial 
pathogens in animals pose a risk not only to animal health but possibly to 
humans via transmission as food-borne pathogens (David et al., 2000). 
          Infections caused by antibiotic-resistant bacteria are a severe and 
costly animal health problem. These infections prolong illness and, if not 
treated in time with more costly, alternative antimicrobial agents, can lead to 
increased morbidity and mortality (David et al., 2000). 
          Multiple-drug resistance in enteric organisms like E.coli is known to 
be associated with integrons. Integrons generally contain an integrase gene 
(intІ) and a cassette interation site (attІ), into which antibiotic resistance 
gene cassette has integrated (Lydia et al., 1999).  
          Antibiotic resistant patterns (ABR) and transferability of the ABR 
markers was investigated in E.coli isolates obtained from drinking water and 
human urine samples. The ABR in E.coli isolates was determined against 
antibiotics commonly used in human and veterinary medicine. A high 
frequency of ABR to carbenicillin (56%), tetracycline (53%), and 
streptomycin (49%), and a low frequency of cefizoxime (5%), amikacine 
(8%), cefazidine (5%), chloramphenicol (9%), and kanamycin (18%) was 
found in the tested E.coli isolates (Walia et al., 2004). 
          Antibiotic resistance among avian bacterial isolates is common and is 
of great concern to the poultry industry. Approximately (36%) of avian 
pathogenic E.coli isolates obtained from diseased poultry exhibited multiple-
antibiotic resistance to tetracycline, oxytetracycline, streptomycin, 
sulfonamides and gentamycin (Lydia et al., 1999). 
          Antibiotic have been used in the prevention and treatment of 
colibacillosis, particularly oxytetracycline, chlortetracycline, streptomycin 
and chloramphenicol, the greatest value has been derived when these 
substances are given orally for several days beginning with 24 hours of birth. 
It has been the practice on some farms to feed antibiotics as a prophylactic 
measure but this has resulted in the development of resistant strains of E.coli 
(Buxton and Frazer, 1977). 
          The use of antibiotics incase of colibacillosis in poultry may be of 
limited value for financial reason and also because of the increasing problem 
of the development of drug resistant strains of E.coli (Buxton and Frazer, 
1977). 
          Chulasiri and suthiekul (1989) illustrated that faecal E.coli isolates 
from healthy farm chickens, from chickens farm with avian influenza and 
and from chickens with diarrhea were more resistant to antimicrobial agents 
than those isolated from healthy domestic chickes. Transfer of drug 
resistance was ready achieved from strains isolated from both healthy and 
sick farm chickens, and from diarrheatic chickens. It was more difficult to 
demonstrate in strains from domestic chicken. 
          Frganis et al., (1989) reported that most isolates of E.coli obtained 
from postmortem materials of hens with septicemia were resistant to 
chloramphenicol, tetracycline, streptomycin, ampicillin, and erythromycin 
and trimethoprim suliamethoxadole but were highly sensitive to gentamycin 
and nalidixic acid. 
          The prophylactic use of sulphonamide to prevent coccidiosis 
(Smith.,et al 1973) may be responsible for the high proportion of E.coli in 
poultry,  resistant to this chemotherapeutic agent. 
          Timms et al. (1989) evaluated the efficacy of chlortetracycline for the 
control of chronic respiratory disease caused by E.coli and Mycoplasma 
gallisepticum and found that medicated food and water reduced the severity 
of air saculitis and other postmortem lesion and lowered mortality. At 
slaughter, resistant strains from the gut readily soil poultry carcasses and as a 
result poultry meats are often contaminated with multi resistant E.coli like 
wise eggs become contaminated during lying. 
          Resistant faecal E.coli from poultry can infect humans both directly 
and via food. These resistant bacteria may colonize the human intestinal 
tract and may also contribute resistance genes to human endogenous flora 
(Bogaard et al., 2001). 
          The susceptibility of different E.coli isolates to different antibiotics at 
the specified concentration was studied (Kamal, thesis). All of the isolates 
were insensitive to penicillin, cloxacillin and erythromycin. Susceptibility of 
the different isolates varied from completely insensitive (resistant) to highly 
sensitive. Ninety four percent of the isolates tested were sensitive to 
chloramphenicol, 82% to ampicillin, 76% to streptomycine and 64% to 
tetracycline and co-trimoxazole. Streptomycin was the least active 
antibiotics against the isolates at the specified concentration. Susceptibility 
to tetracycline and co-trimoxazole was more or less the same. Resistance to 
both drugs was considerably high (more than35%). Also, pattern of 
susceptibility to ampicillin and chloramphenicol was comparable. 
Gentamicin was the only antibiotic to which all isolates were invariably 
sensitive. 
          The invitro activities of anti-microbial agents were determined against 
strains of E.coli isolated from lambs and kids affected by neonatal diarrhea. 
The over all percentage of resistant strains to streptomycine, 
sulphadimethoxine and tetracycline was very high (above 70%). A high 
level of resistant (from 30% to 50%) to ampicillin, kanamycin, neomycin 
and chloramphenicol was also detected. The E.coli strains were highly 
susceptible to cephalosporins, polymyxin and quinolones. Most of the 
strains showed multi resistance, 77.2% of isolates were resistant to at least 
two antibiotics.55.4% were resistant to at least four antibiotics and 33.7 were 
resistant to at least six antibiotics (Cid et al., 1969). 
          Drug resistances of E.coli isolated from the intestinal tract of animals 
reflect their exposure to antibacterial drugs those select resistant clones. 
There is marked variation in resistance, which can be related to the 
antibacterial drugs used in animals in an area. Initial choice of an 
antibacterial must therefore be based on knowledge of usual patterns of 
resistance of E.coli isolates from a particular animal host in the area, and it is 
important to conduct antimicrobial susceptible to fluorquinolone, third 
generation cephalosporins, carbdox, gentamicin, trimethoprim, 
sulphaonamide and nitrofurans, isolates are likely to be resistant to 
streptomycin, sulphonamides and tetracyclines and amodrate percentage of 
strains are likely to be susceptible to chloramphenicol, ampicillin, neomycin 
and kanamycin (Gyles et al., 1993). E.coli that have multiple drug resistance 
patterns and are part of the normal flora may invade to produce septicaemia 
in calves and foals with failure passive transfer (radostitis et al., 1994).  
          Antibiotics should be given parent rally in case of acute mastitis 
caused by E.coli. Oxytetracycline, chlortetracycline and streptomycin given 
intramuscularly have been effective in the treatment of this condition.                     
          Chauhan and Kaushik (1991) reported that the majority of isolates 
from enterotoxigenic E.coli from camel with diarrhea were susceptible to 
gentamycin, nitrofuranation, trimethoprin plus sulfonamide, neomycin, 
kanamycin and chloramphenicol. 
          Shears et al. (1987) investigates antibiotic resistance in gut 
commensals obtained from children presenting with diarrhea in Khartoum 
and Juba, Escherichia coli isolates were obtained from the faeces of 
children. Sensitivity to six antibiotics generally available in Sudan was 
determined for all isolates using a disc diffusion method. The children 
isolates (74%) had resistant to at least four of the antibiotics and (20%) 
isolates had resistant to all six antibiotics. A greater number of resistant 
isolates was obtained from inpatients than out patients but were significantly 
different for only two antibiotics. There was no significant difference in the 
prevalence of resistant isolates obtained from children below 1 year of age. 
The results suggest that multiply resistant E.coli may be a quired from the 
environment, and may play a role in the epidemiology of multiply resistant 
enteric pathogens.  
          Newman and Seidu (2002) examined strains of E.coli investigate the 
frequency of resistance to eleven different antimicrobial agents, 68% of 
these isolates were resistant to tetracycline, and 57% were resistant to 
ampicillin and cotrimoxazole. One strain of E.coli was resistant to eight 
antimicrobials. Thirty percent of the E.coli was resistant to gentamicin. 
          Macias (2002) studied the rate of antibiotic resistance of fecal E.coli 
from healthy children. He found the heist rate of resistance was that to 
tetracycline, Ampicilline and trimethoprim. The resistance to ciprofloxacin, 
amikacin, gentamicin and ceftriaxone was less than 5%. Resistance to five or 
more antimicrobials was detected in 20.39% isolates. 
          E.coli strains isolated from patients with urinary tract infections were 
investigated for their antibiotic susceptibility. The strains were found to be 
highly susceptibility to gentamicin and bactrim (R) (Soyletir and Gumalp, 
1985). 
          Antimicrobial sensitivity tests were performed on bacterial isolates 
from Sudanese patients with diarrhea or urinary tract infections. Entero-
pathogenic E.coli showed high resistance rates against the commonly used 
antimicrobial agents: ampicillin, amoxicilline, chloramphenicol, tetracycline, 
cotrimoxazole, nalidixic acid, sulfonamide and neomycin, and were 
complately sensitive to ciprofloxacin. Resistance to ampicillin, amoxicillin, 
tetracycline, cotrimoxazole and sulfonamide was the most frequent pattern. 
E.coli showed high rates of resistance to ampicillin, amoxicillin, 
cotrimoxazole, tetracycline, sulfonamide, trimethoprim, streptomycin, and 
carbenicillin (Ahmed et al., 2000).       
          
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER TWO 
 
2                       MATERIAL AND METHODS 
 
2.1 Sterilization   
 
2.1.1 Flaming      
          It was used to sterilize glass slides, cover slips, needles and scalpels. 
2.1.2 Red heat 
          It was used to sterilize loop wires, points and searing spatulas by 
holding them over Bunsen burner flame until became red-hot. 
2.1.3 Hot air oven 
          It was used to sterilize glassware such as test tubes, graduated 
pipettes, flasks, forceps and cotton swabs. The holding period was one hour 
and oven temperature was 180ºC. 
2.1.4 Steaming at 100ºC 
          Repeated steaming (Tyndallization) was used for sterilization of 
sugars and media that could not be autoclaved without deteriment effect to 
their constituents. It was carried out as described by Cruckshank et al. 
(1975). 
2.1.5 Moist heat (Autoclave) 
          Autoclaving at 121ºC (151b/inch²) for 15 minutes was used for 
sterilization of media and plastic wares. Autoclaving at 115ºC (101b/inch²) 
for 10 minutes was used for sterilization of some media. 
 
 
 
2.2 Reagents and indicators 
2.2.1 Reagents: 
2.2.1.1 Alpha-naphthol solution: 
          Alpha-naphthol is product of British Drug House, London (BDH). 
This reagent was prepared as 5% aqueous solution for Voges-Proskauer 
(VP) test. 
2.2.1.2 Potassium hydroxide: 
          It was used for Voges-Proskauer test and was prepared according to 
Barrow and Feltham (1993) as 4% aqueous solution. 
2.2.1.3 Hydrogen peroxide: 
          This reagent was obtained from Agropharm Limited, Buckingham. It 
was prepared as 3% aqueous solution and it was used for catalase test. 
2.2.1.4 Methyl red reagent: 
          It was prepared by dissolving methyl red (0.04g) in ethanol (40ml). 
The volume was made to 100ml with distilled water. It was used for methyl 
red test. 
2.2.1.5 Tetramethyl-p-phenylenediamine dihyadrochloride 
          This was prepared in a concentration of 30% aqueous solution and 
was used for oxidase test. 
2.2.1.6 Kovac’s reagent   
          This reagent composed of 5g para-dimethylaminobenzaldehyde, 75ml 
amyl alcohol and 25ml concentrated hydrochloric acid. It was prepared as 
described by Barrow and Feltham (1993) by dissolving the aldehyde in the 
alcohol by heating in water bath. It was then cooled and the acid was added. 
The reagent was stored at 4ºC for later use in indole test. 
 
2.2.2 Indicators 
2.2.2.1 Andrade’s indicator  
          It composed of acidic fuchsin 5g, distilled water 1L and N-NaOH 
150ml. The acid fuchsin was dissolved in distilled water, then the alkali 
solution was added, mixed and was allowed to stand at room temperature for 
24h with frequent shaking until the color changed from red to brown. 
2.2.2.2 Bromothymol blue  
          It was obtained from BDH. The solution was prepared by dissolving 
0.2g of the bromothymol blue powder in 100ml distilled water. 
2.2.2.3 Phenol red  
          It was obtained from Hopkins and William Ltd, London. It was 
prepared as 0.2% in distilled water. 
2.2.3 Preparation of media   
2.2.3.1 Nutrient broth  
          Thirteen grams of nutrient broth (Oxoid) were added to one liter of 
distilled water, mixed well and distributed in 3ml amount into clean test 
tubes, then sterilized by autoclaving at 121ºC for 15 minutes. 
2.2.3.2 Peptone water  
          Fifty grams of peptone water powder (Oxoid) were added to one liter 
of distilled water, mixed well, distributed in 3ml amount into clean test tube 
and sterilized by autoclaving at 121ºC for 15 minutes. 
2.2.3.3 Peptone water sugars  
          This medium was prepared according to Barrow and Feltham (1993). 
Nine hundred ml of peptone water were prepared and the pH was adjusted to 
7.1- 7.3. Ten ml of Andrade’s indicator were added. 
          Sugar solution was prepared by dissolving 10 grams of the appropriate 
sugar in 90 ml of peptone water. This sugar solution was added to the 
peptone water, distributed in 5 ml volume into sterile test tubes with inverted 
Durham’s tubes and sterilized by autoclaving at 115ºC for 10 minutes. 
2.2.3.4 Glucose phosphate medium (MR-VP test medium) 
          This medium was prepared according to Barrow and Feltham (1993). 
Peptone 5g and 5g of phosphate buffer (K2HPO4) were added to one liter of 
distilled water, dissolved by steaming, filtered and pH was adjusted to 7.5. 
Then five grams of glucose were added, mixed well, distributed into clean 
test tubes and sterilized by autoclaving at 115ºC for 15 minutes. 
2.2.3.5 Nutrient agar  
          To one liter of nutrient broth (Oxiod) 15g of agar were added, 
dissolved by boiling, sterilized by autoclaving at 121ºC for 15 minutes. Then 
cooled to about 50ºC and distributed in 15ml amount per plate. The poured 
plates were left to solidify at room temperature on leveled surface.  
2.2.3.6 Diagnostic sensitivity test agar  
          This medium was supplied by Oxiod. It consists of protease peptone, 
veal infusion solids, dextrose, sodium chloride, disodium phosphate, sodium 
acetate, adenine sulphate, guanine hydrochloride, uracil, xanthine, and ion 
agar No.2. 
          Forty grams of the medium were suspended in one liter of distilled 
water, and then brought to boil to dissolve completely, sterilized by 
autoclaving at 121ºC for 15 minutes, then dispended into sterile Petri dishes 
in portions of 15ml each. The poured plates were left to solidify at room 
temperature on leveled surface. 
 
 
2.2.3.7 MacConkey’s agar 
          Fifty two grams of MacConkey’s agar (Oxoid) were suspended in one 
liter of distilled water, brought to boil to dissolve the ingredients completely, 
then sterilized by autoclaving at 121ºC for 15 minutes and poured into sterile 
Petri dishes in 15ml amount. The poured plates were left to solidify at room 
temperature on flat surface. 
2.2.3.8 Motility medium-Cragie tube medium 
          Thirteen grams of dehydrated nutrient broth (Oxoid) were added to 5 
grams of Oxoid agar No-1 and dissolved in one liter of distilled water. The 
pH was adjusted to 7.4. This medium was dispensed in volumes of 5ml into 
20ml test tubes containing the appropriate Cragie tubes, then the medium in 
the test tubes were sterilized by autoclaving at 121ºC for 15 minutes. 
2.2.3.9 Hugh and Leifson’s (O/F) medium 
          This medium was prepared as described by Barrow and Feltham 
(1993). Two grams of peptone powder, five grams of sodium chloride, 0.3g 
of potassium hypophosphate and three grams of agar were added to one liter 
of distilled water, then heated in water bath at 55ºC to dissolve the solids. 
The pH was adjusted to 7.1 and filtered. Then the indicator bromothymol 
blue (0.2% aqueous solutions) was added and the mixture was sterilized at 
115ºC for 10 minuets. Filtered sterile glucose solution was added aseptically 
to give final concentration of 1%. Then the medium was mixed and 
distributed aseptically in 10ml amount into sterile test tubes of not more than 
16mm diameter. 
2.2.3.10 Urea agar medium  
          This medium was supplied by Oxoid. It consist of peptone (1g), 
dextrose (1g), Na2HPO4 (1.2g), KH2PO4 (0.8), sodium chloride (5g), Agar 
(15g) and phenol red (0.012g). Dehydrated medium (2.4g) were suspended 
in 95 ml of distilled water and brought to boil to dissolve completely. The 
pH was approximately adjusted to 6.8 and then it was sterilized by 
autoclaving at 115ºC for 20 minutes. Then cooled to 50ºC and aseptically 
5ml of sterile 40% urea solution was added and mixed well. The medium 
was then distributed in 10 ml amounts into sterile McCartney bottles and 
allowed to set in a slope position. 
2.2.3.11 Simmon’s citrate medium 
          The dehydrated medium of (Difco) consist of ammonium dihydogen 
phosphate (1g), magnesium sulphate (0.2g), K2HPO4 (1g), sodium citrate 
(2g), sodium chloride (5g), Bacto-agar (15g) and Bacto-bromothymol 
blue(0.08g).  
          According to the manufacture 24g of the medium were dissolved in 
one liter of distilled water and pH was adjusted to 6.8. Then sterilized by 
autoclaving at 115ºC for 20 minutes, distributed into MacCarteny bottles and 
allowed to solidify in a slope position. 
2.2.4 Collection of samples 
          A total of one hundred and ninety samples were collected. One 
hundred samples were collected from infected poultry, twenty from calf 
feces showed diarrhea, fifteen from mastitic cow’s milk, fifteen from women 
urine with urinary tract infection and ten from bovine abscesses. Thirty swab 
samples were collected from child diarrhea patients at Omdurman Pediatric 
hospital. 
2.2.5 Transportation of samples  
          Samples were collected in sterile MacCarteny bottles and labeled and 
kept on ice. All samples were cultured 2-3 hours after collection or kept 
frozen at -20ºC. 
2.2.6 Culture of specimens  
          The collected samples were inoculated onto MacConkey agar. The 
inoculated plates were then incubated for 24 hours at 37ºC. 
          After the incubation period the characteristic colonies were observed 
and smears were made from lactose fermenting, red or pink colonies. Then 
dried in the air, fixed by heating, stained by Grams method and examined 
under light microscope for cell morphology and staining reaction.   
2.2.7 Purification  
          Isolates were purified by several subculturing from single well- 
separated colony on nutrient agar plates. The purity was checked by 
examining Gram stained smear. The pure culture was then used for studying 
cultural and biochemical characteristics and antibiotics’ sensitivity. 
2.2.8 Microscopic examination  
          Smears were made from colonies on primary culture and from purified 
colonies, fixed by heating and stained by Gram method (Barrow and 
Feltham, 1993), then examined microscopically by oil immersion. The 
smear was examined for cell morphology and staining reaction. 
2.2.9 Identification of bacteria  
          The purified isolates were identified according to the criteria described         
by Barrow and Feltham (1993). This included staining reaction, organism 
morphology, growth condition, and the colonies characteristics on different 
media, motility and biochemical characteristics. 
2.2.10 Biochemical methods  
2.2.10.1 Catalase test 
          The test was carried out as described by Barrow and Feltham (1993). 
A drop of 3% aqueous solution of hydrogen peroxide was placed on a clean 
slide. Small amount of the tested organism colony on nutrient agar was 
picked by glass rod, added to the drop and mixed.  Production of air bubble 
indicated positive result.  
2.2.10.2 Oxidase test 
          The method of Barrow and Feltham (1993) was used. Strip of filter 
paper was soaked in 1% solution of tetra methyl-p-phenylene diamine 
dihydrochloride and dried in hot air oven and then placed on clean glass 
slide by sterile forceps. A fresh young tested culture on nutrient agar was 
picked off with sterile glass rod and rubbed on the filter paper strip. If a 
purple color developed within 5-10 seconds, the reaction was considered 
positive. 
2.2.10.3 Oxidation- fermentation test   
          The test was carried out as described by Barrow and Feltham (1993). 
The tested organism was inoculated with straight wire into duplication of 
test tubes of Hugh and Leifeson’s medium. To one of the test tube a layer of 
melted soft paraffin oil was added to the medium to seal it from air. The 
inoculated tubes were incubated at 37ºC and examined daily for fourteen 
days. Yellow color in open tube only indicated oxidation of glucose; yellow 
color in both tubes showed fermentation reaction and blue or green color in 
open tube indicated production of alkali. 
2.2.10.4 Sugar fermentation test  
          The test was carried out as described by Barrow and Feltham (1993). 
The peptone water sugar was inoculated with organism under the test, 
incubated at 37ºC and then examined daily for several days. Acid production 
was indicated by appearance of redish color, while gas production was 
indicated by presence of empty space in the inverted Durham’s tubes. 
 
2.2.10.5 Citrate utilization  
          To test the ability of the test organism to utilize citrate as a sole source 
of carbon, heavy inoculum was cultured on the surface of a slope of 
Simmon’s citrate medium and incubated at 37ºC and examined daily. A 
positive test was indicated by change of color from green to blue. A negative 
test was not considered before end of 14 days. 
2.2.10.6 Urease activity 
          Urease activity is shown by alkali production (ammonia) from urea 
splitting by the test organism. Heavy inoculum was cultured on the surface 
of urea agar slope and incubated at 37ºC and examined daily. A positive test 
was indicated by pink or red color. A negative result was not considered 
before end of 7 days. 
2.2.10.7 Indole production test   
          Indole production test was carried out as described by Barrow and 
Feltham (1993). The tested organism was inoculated into peptone water and 
incubated at 37ºC for 48 h. One milliliter of the Kovacs reagent was run 
down along side of the test tube. Appearance of pink color in the reagent 
layer within a minute indicated positive reaction. 
2.2.10.8 Methyl red test   
          Methyl red test was carried out as described by Barrow and Feltham 
(1993). The tested organism was inoculated into glucose phosphate medium 
(MR.VP medium), then incubated at 37ºC for 48 h. Two drops of methyl red 
reagent were added, shaken well and examined. Appearance of red color 
indicated positive reaction. 
2.2.10.9 Voges- Proskauer test 
          The test was performed as described by Barrow and Feltham (1993). 
The test culture was inoculated into glucose phosphate medium (MR.VP 
medium) and incubated at 37ºC for 48 hours. Then 0.6 ml of 5% α- naphthol 
followed by a 0.2 ml of 40% potassium hydroxide aqueous solution were 
added to one ml of the culture, shaked well and examined after 15 minutes. 
A positive reaction was indicated by appearance of bright pink colour. 
2.2.10.10 Motility test 
          Craigi tube in semi- solid nutrient agar, prepared as described before 
(2.2.3.8). A small piece of the colony of the bacterium under test, was 
picked by the end of the straight wire and stabbed in the center of semi- sold 
agar in the Craigi tube and then incubated at 37ºC overnight. The organism 
was considered motile if there was turbidity in the medium in and outside 
the Craigi tube. 
2.2.10.11 Antibiotic sensitivity            
          Sensitivity of isolates to a number of antibiotics was determined by 
disc diffusion technique (Cruckshank et al., 1975). The isolate was grown on 
peptone water and incubated at 37ºC for two hours. One to two ml of the 
culture was poured on a Petri dish containing diagnostic sensitivity test agar 
medium (DST) and dried in oven at 40ºC for 20 minutes before the 
inoculation. The inoculum was evenly distributed by rotation. Excess fluid 
was withdrawn using sterile Pasteur pipette and plate was let to dry at room 
temperature for 15 minutes. Commercial discs obtained from Axiom 
Laboratories (India) were placed on the surface of the medium by sterile 
forceps, pressed gently to ensure full contact with the surface of the culture 
medium. The plates were then incubated at 37ºC for 24 hours and up to 48 h. 
After incubation, the plates were examined for growth inhibition around disc 
and the diameter of zone of growth inhibition was measured in millimeters. 
The antibiotics examined in this study were: amoxicillin 10µg , amikacin 
30µg, ceftizoxime 30µg, chloramphenicol 30µg, cephalexin 30µg, 
tetracycline  30µg, ciprofloxacine 5µg, nitrofuranation 300µg, nalidixic acid 
30µg, gentamicin 10µg, norfloxacin 10µg, ofloxacin 5µg, ampicillin 20µg, 
co- trimoxazole 25µg and pefoxacin 10µg (Table 1). 
2.2.10.12 Isolation of plasmid DNA   
          To confirm the presence of extrachromosomal DNA in E.coli strains, 
it was necessary to isolate plasmid DNA and to detect it using conventional 
Agarose electrophoresis. A modified version from the methods described by 
Kado (1981) and Oslen (1990) was used to isolate plasmid DNA. Overnight 
culture was harvested by centrifugation at 2500 g/10 min and resuspended in 
40 µl 50 mM tris EDTA, pH 8.0. The cells were lysed at 56 ºC/1 h in 400 µl 
3% SDS, 50 mM tris, pH 12.5. After addition of 300 µl 1.5 M K acetate, pH 
5.2, the suspension was left for 20 min on ice. The supernatant fluid was 
cleared from the precipitate by centrifugation at 2400 g/10 min. The 
supernatant was treated once with an equal volume of chloroform: phenol 
(1:1, v/v). The phases were separated by centrifugation for 15 min at 2400 
g/4 ºC and the upper phase was transferred to tube. 100 µl of 3 M sodium 
acetate and 800 µl of 96% ethanol were added and the mixture was left at 4 
ºC for 30 min. Plasmid DNA was collected by centrifugation at 6720 g/15 
min at 2 ºC and resuspended in 100 µl buffer or autoclaved water. 
          Five strains of E.coli, 67b (sensitive), 131 (resistant to two 
antibiotics), 71 (resistant to four antibiotics), 10 (resistant to six antibiotics) 
and 67a (resistant to eight antibiotics) were examined. 
2.2.10.13 Detection of plasmid DNA    
          Twenty µl of aqueous phase containing native plasmid was mixed 
with 5 µl of 0.025 % bromophenol blue (MERCK) and xylene cyanole FF 
(SIGMA) in 50 % glycerol in TAE buffer (40 mM Tris, 5mM sodium 
acetate, 1mM EDTA, pH 8) and separated for 2 h on 0.7 % horizontal 
Agarose gel at a current of  100 V in 1x TAE buffer. 
          Ladder (100 bp) was used as molecular weight marker. Gels were 
stained with ethidium bromide (0.25 µg/ml) photographed under UV light 
and printed.  
  
      
 
           
  
                
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER THREE 
3 RESULTS 
3.1 Survey 
          A total of one hundred and ninety samples were collected. One 
hundred samples were collected from infected poultry tissues, twenty from 
feces of calves showing diarrhea, fifteen from milk of mastitic cow’s, fifteen 
from urine of women with urinary tract infection, ten from bovine abscess 
and thirty swab samples were collected from cases of child diarrhea at 
Omdurman pediatric hospital. 
          Collected samples were cultured onto MacConkey agar and incubated 
aerobically at 37ºC.  
          E.coli was isolated from eighty one poultry samples, twelve calf fecal 
samples, nine mastitic cow’s milk, eight women urine, two bovine abscess 
and twenty child diarrhea samples (Table 1).     
3.2 Growth on solid media 
A  MacConkey’s agar 
          On MacConkey’s agar medium large, profuse, smooth pink colonies, 
2-3 mm in diameter were seen (Figure 1). 
B  Nutrient agar  
          On nutrient agar colonies were small and more mucoid than on 
MacConkey’s agar (Figure 2). 
3.3 Microscopic and cultural characteristics of the isolates 
          Microscopic examination of isolates revealed Gram-negative short 
rods, occurring singly or in pairs. 
 
3.4 Growth in liquid media 
          A heavy turbidity was produced by all the isolates in peptone water 
following overnight incubation. There was a heavy deposit which was easily 
dispersed by shaking. Incubation of cultures for six hours resulted in slightly 
turbid growth without deposit. 
3.5 Biochemical characteristics of the isolates 
3.5.1 Oxidase test  
          All the isolates were oxidase negative. 
3.5.2 Catalase test    
          All isolates were catalase positive, producing O2 gas that appears in 
the form of bubbles. 
3.5.3 Sugar fermentation test 
          On sorbitol all strains of E.coli fermented sorbitol with production of 
acid and gas, and fermented glucose with production of acid and gas. Acid 
was indicated by change in the colour of the medium to pink. Gas 
production was indicated by appearance of air bubbles at the top of 
Durham’s tube. 
3.5.4 Oxidation fermentation test 
          All isolates of E.coli were oxidative and fermentative. 
3.5.5 Indole test 
          All strains of E.coli examined were able to produce indole when 
inoculated into peptone water. 
3.5.6 Voges-Proskauer test 
          All strains of E.coli were unable to produce acetyl methyl carbinol in 
phosphate glucose medium and hence the colour of the medium was not 
changed to red when alpha- naphthol and potassium hydroxide were added 
to the tested culture. 
3.5.7 Methyl red test 
          All strains of E.coli were methyl red positive. 
3.5.8 Citrate utilization test  
          All strains were unable to utilize citrate when inoculated into 
Simmon’s citrate medium. 
3.6 Antibiotic sensitivity:  
          The antibiotic sensitivity of E.coli isolates of this study was examined 
against 15 antibacterial agents by using the disc diffusion technique (Figure 
3). 
          Infected poultry isolates were completely sensitive to amikacin 
(100%) and ceftriaxom (100%). While child diarrhea isolates were 
completely sensitive to cephalexin (100%), nitrofuranation (100%), nalidixic 
acid (100%) and ofloxacin (100%). Also women urine isolates were 
completely sensitive to amikacin (100%), ceftizoxim (100%), 
chlormaphenicol (100%), nitrofuranation (100%) and pefoxacin (100%). 
          Mastitic cow’s milk isolates were completely sensitive (100%) to 
amikacin, ceftizoxim, chlormaphenicol, cephalexin, ciprofloxacin, 
nitrofuranation, nalidixic acid, gentamicin, norfloxacin, ofloxacin, ampicillin  
pefolxacin and co- trimoxazole, except amoxicillin (67%) and tetracycline 
(67%) showed resistance. 
          Child diarrhea isolates showed some resistance to amoxicillin (60%), 
tetracycline (70%), norfloxacin (55%), ampicillin (55%) and co- trimoxazol 
(55%). While nalidixic acid showed complete effectiveness (100%) against 
child diarrhea isolates. 
          Women urine isolates showed high resistance to tetracycline (75%), 
and intermediate susceptibility to amoxicillin (50%), ampicillin (50%) and 
co- trimoxazol (50%) and showed high susceptibility (75%) to gentamicin. 
          Calf feaces isolates were completely sensitive (100%) to amikacin, 
ceftizoxim, chlormaphenicol, cephalexin, nitrofuranation, gentamicin, 
ofloxacin, ampicillin, pefolxacin and co- trimoxazole. 
          Also calf feaces isolates showed high sensitivity to ciprofloxacin 
(92%), norfloxacin (92%), nalidixic acid (75%) and showed intermediate 
sensitivity to tetracycline (58%).             
          Bovine abscess isolates were completely sensitive (100%) to most 
antibiotics however, bovine sove isolates were completely resistant (100%) 
to amoxicillin, tetracycline, nalidixic acid, ofloxacin. While ciprofloxacin 
and norfoxacin showed intermediate effectiveness (50%). 
          The multiple drug- resistance observed in this study varied from two 
drugs multiple resistances (tetracycline and nalidixic acid) to nine drugs 
multiple resistances (chloramphenicol, cephalexin, tetracycline, 
ciprofloxacin, nalidixic acid, norfloxacin, ofloxacin, ampicillin and 
pefolxacin).  
          E.coli strains showed the highest multiple drugs resistance were 
isolated from infected poultry tissues (up to 9 antimicrobial drugs) women 
urine (up to 7 antimicrobial drugs) and bovine abscess (up to 6 antimicrobial 
drugs). 
          Most of the strains examined showed multi- resistance; as 75.7% of 
isolates were resistant to at least two antibiotics, 59.8% were resistant to at 
least three antibiotics, 43.1% were resistant to at least four antibiotics, 25.7% 
were resistant to at least five antibiotics, 18.9% were resistant to at least six 
antibiotics, 9% to at least 7 antibiotics, 3% to at least 8 antibiotics and 1.5% 
to at least 9 antibiotics.   
          The sensitivity of tested isolates to the different antibacterial agents 
was variable (Tables 2, 3, 4, 5, 6, 7, 8). Some isolates were sensitive to all 
antibacterial agents 10 (7.5%), while others were resistant to one 
antibacterial agent 22 (16.6%), two antibacterial agents 21 (15.9%), three 
antibacterial agents 22 (16.6%), four antibacterial agent 23 (17.4%), five 
antibacterial agents 9 (6.85), six antibacterial agents 13 (9.8%), seven 
antibacterial agents 8 (6%), eight antibacterial agents 2 (1.5%) and nine 
antibacterial agents 2 (1.5%) (Table 9). 
3.7 Detection of plasmid DNA   
          In this study, five E.coli isolates were examined for plasmid DNA. 
The isolates did not show clear bands of plasmid (Figure 4).    
 
 
 
 
 
 
 
 
 
 
 
 
 Table 1: Isolation of E.coli from different sources 
Source of 
samples 
Number of 
samples 
examined 
Number of 
isolates 
recovered 
Isolation rate  
Infected poultry 
tissues 
100 81 81 % 
Calf fecal 
sample 
20 12 60 % 
Mastitic cow’s 
milk  
15 9 60 % 
Women urine  15 8 53.3 % 
Bovine abscess 10 2 20 % 
Child diarrhea  30 20 66.7% 
Total 190 132 69.47% 
 
 
 
 
 
 
 
 
Table 2: Antibiotic sensitivity of E.coli isolated from different 
sources  
Antibiotic  Number of 
bacteria 
examined  
No. of isolates 
 
Sensitive          
(percentage) 
No. of isolates 
 
Resistant          
(percentage) 
Amoxicillin   
AM- 10 mcg 
132 80       (61%) 52       (39%) 
Amikacin       
AK- 30 mcg 
132 131      (99%) 1        (1%) 
Ceftizoxim       
CI- 30 mcg 
132 131      (99%) 1        (1%) 
Chloramphenicol 
CH- 30 mcg 
132 96       (73%) 36       (27%) 
Cephalexin      
PR- 30 mcg 
132 125      (95%) 7        (5%) 
Tetracycline    
TE- 30 mcg 
132 29       (22%) 103      (78%) 
Ciprofloxacin   
CP- 5 mcg 
132 104      (78%) 28       (22%) 
Nitrofurantion    
FD- 300 mcg 
132 126      (95%) 6        (5%) 
Nalidixic acid   
NA- 30 mcg 
132 55       (42%) 77       (58%) 
Gentamicin      
GM- 10 mcg 
132 117      (89%) 15       (11%) 
Norfloxacin     
NX- 10 mcg 
132 104      (78%) 28       (22%) 
Ofloxacin        
OF- 5 mcg 
132 103      (78%) 29       (22%) 
Ampicillin      
AS- 20 mcg 
132 112      (85%) 20       (15%) 
Co- Trimoxazole  
BA- 25 mcg 
132 79       (60%) 53       (40%) 
Pefloxacin       
PF- 10 mcg 
132 96       (73%) 36       (27%) 
 
Table 3: Antibiotics sensitivity of E.coli isolated from infected poultry 
tissues  
Antibiotic No. of isolates 
examined 
No. of isolates 
sensitive  
(percent) 
No. of isolates 
resistant  
(percent) 
Amoxicillin   
AM- 10 mcg 
81 64                
(79%) 
17                     
(30%) 
Amikacin       
AK- 30 mcg 
81 81                     
(100%) 
0                    
(0%) 
Ceftizoxim       
CI- 30 mcg 
81 81                     
(100%) 
0                    
(0%) 
Chloramphenicol 
CH- 30 mcg 
81 47                    
(58%) 
34                     
(42%) 
Cephalexin      
PR- 30 mcg 
81 75                   
(93%) 
6                        
(7%) 
Tetracycline    
TE- 30 mcg 
81 11                      
(14%) 
70                     
(86%) 
Ciprofloxacin   
CP- 5 mcg 
81 62                     
(77%) 
19                       
(23%) 
Nitrofurantion    
FD- 300 mcg 
81 75                     
(93%) 
6                        
(7%) 
Nalidixic acid   
NA- 30 mcg 
81 12                        
(15%) 
69                
(85%) 
Gentamicin      
GM- 10 mcg 
81 69                     
(85%) 
12                        
(15%) 
Norfloxacin     
NX- 10 mcg 
81 67                      
(83%) 
14                      
(17%) 
Ofloxacin        
OF- 5 mcg 
81 57                     
(70%) 
24                       
(30%) 
Ampicillin      
AS- 20 mcg 
81 74                       
(91%) 
7                        
(9%) 
Co- Trimoxazole  
BA- 25 mcg 
81 41                       
(51%) 
40                      
(49%) 
Pefloxacin       
PF- 10 mcg 
81 45                      
(56%) 
36                        
(44%) 
 
 
 
Table 4: Antibiotics sensitivity of E.coli isolated from calf fecal samples 
 
Antibiotic No. of isolates 
examined 
No. of isolates 
sensitive  
(percent) 
No. of isolates 
resistant  
(percent) 
Amoxicillin   
AM- 10 mcg 
12 1                      
(8%) 
11                     
(92%) 
Amikacin       
AK- 30 mcg 
12 12                       
(100%) 
0                        
(0%) 
Ceftizoxim       
CI- 30 mcg 
12 12                       
(100%) 
0                        
(0%) 
Chloramphenicol 
CH- 30 mcg 
12 12                       
(100%) 
0                        
(0%) 
Cephalexin      
PR- 30 mcg 
12 12                       
(100%) 
0                        
(0%) 
Tetracycline    
TE- 30 mcg 
12 7                         
(58%) 
5                     
(42%) 
Ciprofloxacin   
CP- 5 mcg 
12 11                     
(92%) 
1                      
(8%) 
Nitrofurantion    
FD- 300 mcg 
12 12                       
(100%) 
0                        
(0%) 
Nalidixic acid   
NA- 30 mcg 
12 9                
(75%) 
3                       
(25%) 
Gentamicin      
GM- 10 mcg 
12 12                       
(100%) 
0                        
(0%) 
Norfloxacin     
NX- 10 mcg 
12 11                     
(92%) 
1                      
(8%) 
Ofloxacin        
OF- 5 mcg 
12 12                       
(100%) 
0                        
(0%) 
Ampicillin      
AS- 20 mcg 
12 12                       
(100%) 
0                        
(0%) 
Co- Trimoxazole  
BA- 25 mcg 
12 12                       
(100%) 
0                        
(0%) 
Pefloxacin       
PF- 10 mcg 
12 12                       
(100%) 
0                        
(0%) 
 
 
 
 
Table 5: Antibiotics sensitivity of E.coli isolated from mastitic cow’s 
milk 
 
Antibiotic No. of isolates 
examined 
No. of isolates 
sensitive  
(percent) 
No. of isolates 
resistant  
(percent) 
Amoxicillin   
AM- 10 mcg 
9 3                           
(33%) 
6                         
(67%) 
Amikacin       
AK- 30 mcg 
9 9                       
(100%) 
0                         
(0%) 
Ceftizoxim       
CI- 30 mcg 
9 9                
(100%) 
0                         
(0%) 
Chloramphenicol 
CH- 30 mcg 
9 9                       
(100%) 
0                         
(0%) 
Cephalexin      
PR- 30 mcg 
9 9                       
(100%) 
0                         
(0%) 
Tetracycline    
TE- 30 mcg 
9 3                           
(33%) 
6                         
(67%) 
Ciprofloxacin   
CP- 5 mcg 
9 9                       
(100%) 
0                         
(0%) 
Nitrofurantion    
FD- 300 mcg 
9 9                       
(100%) 
0                         
(0%) 
Nalidixic acid   
NA- 30 mcg 
9 9                       
(100%) 
0                         
(0%) 
Gentamicin      
GM- 10 mcg 
9 9                       
(100%) 
0                         
(0%) 
Norfloxacin     
NX- 10 mcg 
9 9                       
(100%) 
0                         
(0%) 
Ofloxacin        
OF- 5 mcg 
9 9                       
(100%) 
0                         
(0%) 
Ampicillin      
AS- 20 mcg 
9 9                       
(100%) 
0                         
(0%) 
Co- Trimoxazole  
BA- 25 mcg 
9 9                    
(100%) 
0                         
(0%) 
Pefloxacin       
PF- 10 mcg 
9 9                       
(100%) 
0                         
(0%) 
 
 
 
 Table 6: Antibiotics sensitivity of E.coli isolated from women urine  
 
Antibiotic No. of isolates 
examined 
No. of isolates 
sensitive  
(percent) 
No. of isolates 
resistant  
(percent) 
Amoxicillin   
AM- 10 mcg 
8 4                        
(50%) 
4                        
(50%) 
Amikacin       
AK- 30 mcg 
8 8                          
(100%) 
0                           
(0%) 
Ceftizoxim       
CI- 30 mcg 
8 8                          
(100%) 
0                           
(0%) 
Chloramphenicol 
CH- 30 mcg 
8 8                          
(100%) 
0                           
(0%) 
Cephalexin      
PR- 30 mcg 
8 7                        
(88%) 
1                      
(12%) 
Tetracycline    
TE- 30 mcg 
8 2                        
(25%) 
6                          
(75%) 
Ciprofloxacin   
CP- 5 mcg 
8 5                      
(63%) 
3                       
(37%) 
Nitrofurantion    
FD- 300 mcg 
8 8                 
(100%) 
0                           
(0%) 
Nalidixic acid   
NA- 30 mcg 
8 5                      
(63%) 
3                       
(37%) 
Gentamicin      
GM- 10 mcg 
8 6                          
(75%) 
2                        
(25%) 
Norfloxacin     
NX- 10 mcg 
8 5                      
(63%) 
3                       
(37%) 
Ofloxacin        
OF- 5 mcg 
8 5                      
(63%) 
3                       
(37%) 
Ampicillin      
AS- 20 mcg 
8 4                        
(50%) 
4                        
(50%) 
Co- Trimoxazole  
BA- 25 mcg 
8 4                        
(50%) 
4                        
(50%) 
Pefloxacin       
PF- 10 mcg 
8 8                          
(100%) 
0                           
(0%) 
 
 
 
 Table 7: Antibiotics sensitivity of E.coli isolated from bovine abscess 
 
Antibiotic No. of isolates 
examined 
No. of isolates 
sensitive  
(percent) 
No. of isolates 
resistant  
(percent) 
Amoxicillin   
AM- 10 mcg 
2 0                      
(0%) 
2                       
(100%) 
Amikacin       
AK- 30 mcg 
2 2                       
(100%) 
0                      
(0%) 
Ceftizoxim       
CI- 30 mcg 
2 2                       
(100%) 
0                      
(0%) 
Chloramphenicol 
CH- 30 mcg 
2 2                       
(100%) 
0                      
(0%) 
Cephalexin      
PR- 30 mcg 
2 2                       
(100%) 
0                      
(0%) 
Tetracycline    
TE- 30 mcg 
2 0                      
(0%) 
2                       
(100%) 
Ciprofloxacin   
CP- 5 mcg 
2 1                      
(50%) 
1                      
(50%) 
Nitrofurantion    
FD- 300 mcg 
2 2                       
(100%) 
0                      
(0%) 
Nalidixic acid   
NA- 30 mcg 
2 0                      
(0%) 
2                       
(100%) 
Gentamicin      
GM- 10 mcg 
2 2                       
(100%) 
0                      
(0%) 
Norfloxacin     
NX- 10 mcg 
2 1                      
(50%) 
1                      
(50%) 
Ofloxacin        
OF- 5 mcg 
2 0                      
(0%) 
2                       
(100%) 
Ampicillin      
AS- 20 mcg 
2 2                       
(100%) 
0                      
(0%) 
Co- Trimoxazole  
BA- 25 mcg 
2 2                       
(100%) 
0                      
(0%) 
Pefloxacin       
PF- 10 mcg 
2 2                       
(100%) 
0                      
(0%) 
 
 
 
 Table 8: Antibiotics sensitivity of E.coli isolated from child diarrhea  
 
Antibiotic No. of isolates 
examined 
No. of isolates 
sensitive  
(percent) 
No. of isolates 
resistant  
(percent) 
Amoxicillin   
AM- 10 mcg 
20 8                    
(40%) 
12                   
(60%) 
Amikacin       
AK- 30 mcg 
20 19                     
(95%) 
1                      
(5%) 
Ceftizoxim       
CI- 30 mcg 
20 19                     
(95%) 
1                      
(5%) 
Chloramphenicol 
CH- 30 mcg 
20 18                      
(90%) 
2                      
(10%) 
Cephalexin      
PR- 30 mcg 
20 20                      
(100%) 
0                         
(0%) 
Tetracycline    
TE- 30 mcg 
20 6                         
(30%) 
14                      
(70%) 
Ciprofloxacin   
CP- 5 mcg 
20 16                        
(80%) 
4                         
(20%) 
Nitrofurantion    
FD- 300 mcg 
20 20                      
(100%) 
0                         
(0%) 
Nalidixic acid   
NA- 30 mcg 
20 20                      
(100%) 
0                         
(0%) 
Gentamicin      
GM- 10 mcg 
20 19                     
(95%) 
1                      
(5%) 
Norfloxacin     
NX- 10 mcg 
20 11                      
(55%) 
9                         
(45%) 
Ofloxacin        
OF- 5 mcg 
20 20                      
(100%) 
0                         
(0%) 
Ampicillin      
AS- 20 mcg 
20 11                      
(55%) 
9                      
(45%) 
Co- Trimoxazole  
BA- 25 mcg 
20 11                      
(55%) 
9                         
(45%) 
Pefloxacin       
PF- 10 mcg 
20 20                      
(100%) 
0                         
(0%) 
 
 
 
 Table 9: Multi- antibiotics resistance of E.coli isolated from different 
sources  
No. of 
antibiotics 
resistant to 
No. of 
isolates 
examined   
No. of multi- 
resistance 
isolates                     
(percentage) 
Source of 
isolation  
O 132 10                         
(7.5%) 
A– B- C- D– 
F 
1 132 22                
(16.6%) 
A– B- C- D– 
F 
2 132 21                                 
(15.9%) 
A– B- C- F 
3 132 22                                
(16.6%) 
A– B- F 
4 132 23                                
(17.4%) 
A– D– E- F
5 132 9                                
(6.8%) 
A– B- F 
6 132 13                                 
(9.8%) 
A– D– E  
7 132 8                                  
(6%) 
A– D
8 132 2                                  
(1.5%) 
A
9 132 2                                  
(1.5%) 
A
10 132 O                  
(0%) 
- 
11 132 O                                  
(0%) 
- 
12 132 O                                  
(0%) 
- 
 
 
A: Infected poultry tissues                              B: Calf fecal samples 
C: Mastitic cow’s milk                                    D: Women urine 
E: Bovine abscess                                            F: Child diarrhea 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
Fig. 1: E.coli on MacConkey’s agar 
  
 
 
 
 
 
 
 
 
 
 
 
        Figure 2: E.coli on Nutrient agar 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
   Fig.3: Antibiotics sensitivity of E.coli. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Fig 4: Agarose gel (0.7%) electrophoresis of plasmid DNA from E.coli 
isolates. lane 1 ladder plasmid (100 bp), lane 2 strain 67b (sensitive), lane 3 
strain 131(2 drugs resistant), lane 4 strain 71(4 drugs resistant), lane 5 strain 
10 (6 drugs resistant), lane 6 strain 67a (8 drugs resistant).  
 
 
 
 
 
 
 
 
CHAPTER FOUR 
 
DISCUSSION  
           
          This study was carried out to detect the drug- resistance in E.coli 
isolated in Khartoum State and also to compare the plasmids size of E.coli 
isolates having different multiple drug resistance. 
          Eighty-one isolates of E.coli were obtained from infected poultry 
tissues. This result is in agreement with Bass et al. (1999) who reported that 
E.coli adversely affects avian species through infection of the blood, 
respiratory tract, and soft tissues. 
          This study showed a high prevalence of antimicrobial drug resistance 
in E.coli isolated from poultry. Infected poultry isolates showed resistance to 
tetracycline (86%) and nalidixic acid (85%). This result confirms the finding 
of Bass (1999) who reported antibiotic resistance among avian bacterial 
isolates and most isolates were resistance to tetracycline. Also this finding 
agrees with El- Gasim (1999) who observed resistance to nalidixic acid 
among poultry isolates. This may indicate increasing in the use of nalidixic 
acid whether in treatment of colibacillosis or poultry formulas.  
          Eight isolates of E.coli were obtained from women with urinary tract 
infection. This finding agrees with El sheikh (2004) who reported the 
presence of E.coli in pregnant women with urinary tract infection.   
          Women urine isolates showed susceptibility to amikacin (100%), 
ciprofloxacin (63%), nitrofuranation (100%), gentamicin (75%) and 
norfoxacin (63%). This finding agrees with Jose et al. (2002) who reported 
that, E.coli isolated from urinary tract infections showed high susceptibility 
to amikacin (97%), gentamicin (94%), nitrofurantoin (89%), norfloxacin 
(81%) and ciprofloxacin (78%). Also this finding agrees with Soyletir and 
Gumalp (1985) who found that E.coli strains isolated from patients with 
urinary tract infections were susceptible to gentamicin (75%). The isolates of 
this study showed medium susceptibility (50%) to ampicillin. This result is 
similar to that reported by Jose et al. (2002) who stated that, there was a low 
susceptibility pattern of E. coli isolated from urinary tract infections to 
ampicillin (41%). 
           Women urine isolates of this study showed resistance to tetracycline 
(75%). Which is contrast to the finding of El sheikh (2004) who stated that 
(50%) of the E.coli strains obtained from pregnant women with urinary tract 
infection were resistant to tetracycline. Most of the strains showed multi- 
resistance (87.8%) this finding agrees with those of Guyot et al., (1999) who 
stated that, thirty-  two multi- resistant E.coli strains were isolated from the 
urine of thirteen patients with chronic urinary tract infection.   
          Twelve isolates of E.coli were obtained from calf feaces. This finding 
agrees with Ellaithi (2004) who reported the isolation of E.coli from 80% of 
faeces of diarrhoic calves in the Sudan.  
          Calf feaces E.coli isolates of this investigation were completely 
sensitive to gentamicin (100%). This finding agrees with Altom (2000) who 
reported that E.coli isolates from animals with diarrhea were sensitive to 
gentamicin. Also this finding is in agreement with Orden (2000) who found 
that, E.coli strains isolated from diary calves affected by neonatal diarrhea 
were very susceptible (89- 95%) to gentamicin. 
         Nine isolates of E.coli were obtained from mastitic cow’s milk. This 
result is in agreement with that of Elgadasi (2003) who isolated E.coli from 
mastitic milk of cattle, sheep and goats collected 3 days after treatment, in 
Khartoum State.          
          Mastitic cow’s milk isolates were completely sensitive to amoxicillin 
(100%), ceftizoxime (100%), chloramphenicol (100%), cephalexin (100%), 
ciprofloxacine (100%), nitrofuranation (100%), nalidixic acid (100%), 
gentamicin (100%), norfloxacin (100%), ofloxacin (100%), ampicillin 
(100%), co- trimoxazole (100%) and pefoxacin (100%). This finding agrees 
with Mohamed (2005) who stated that E.coli isolated from mastitic cow’s 
milk showed complete sensitivity to gentamicin (100%), nalidixic acid 
(100%), nitrofuranation (100%). However, Elgadasi (2003) isolates were 
less sensitive than isolates of this study to chloramphenicol (80 vs 100%) 
and gentamycin (69.1 vs 100%) and also were less sensitive than 
Mohammed (2005) isolates. This probably, because, Elgadasi (2003) isolates 
were recoverd from milk treated with three drugs.  
          Mastitic cow’s milk isolates of this study showed resistance to 
tetracycline (67%). This finding does not agree with Mohamed (2005) who 
reported that mastitic cow’s milk isolates were completely sensitive to 
tetracycline (100%). The high multi drug resistance observed in mastitic 
cow’s milk isolates of the present study can be attributed to extensive and 
intensive use of different intramammary preparation for the treatment of 
mastitis in lactating diary cattle.  
          Twenty isolates of E.coli were obtained from child diarrhea. This 
result is in agreement with Shears et al. (1987), who obtained fifty- one 
isolates of E.coli from stools of thirty- four children in Sudan.  
          Child diarrhea isolates of the present study showed resistance to 
amoxicillin (60%) and tetracycline (70%) and most of the strains showed 
multi- resistance (85%). This result confirms the finding of Shears et al., 
(1987) who stated that sensitivity to six antibiotics, generally available in 
Sudan, were determined for E.coli isolated from children with diarrhea. 
Twenty- five (74%) of the children had isolates resistant to at least four of 
the antibiotics, and seven (20%) had isolates resistant to all six antibiotics. 
The isolates of child diarrhea in the present study showed complete 
susceptibility (100%) to nalidixic acid. This finding agrees with Malkawi 
and Youssef (1998) who stated that all E.coli isolates recovered from 
specimens of children with diarrhea were sensitive to nalidixic acid.  
          The high prevalence of resistance to tetracycline observed in E.coli 
isolated from animals in this study can be attributed to many factors; the 
extensive use of oxytetracycline in the treatment of the diseases, Sub- dosing 
and incomplete duration of treatment. 
          Multi- drug resistance was shown by most of E.coli strains (75.5%) 
isolated in present study and the multiple drug resistance observed varied 
from two multiple drug resistant to nine multiple drug resistant. This result is 
similar to that reported by Mohammed (2005) who observed 12 antibiotics 
multi drugs resistance among E.coli strains isolated from mastitic milk. This 
finding agrees with Cohen (1992) who reported multi- drug resistance in 
Escherichia and some others Gram- negative bacteria. Resistant 
enterobacteriaceae frequently contain multiple plasmids, the larger of which 
can carry genes for resistance to 10 or more antimicrobial agents (Jacoby, 
1991). This may explain the very high multiple- drug resistance of E.coli (up 
to 9 antimicrobial agents) observed in this study. All E.coli isolated in this 
study were resistant to one or more of beta- lactam ring antibiotics. This 
probably due to the fact that Gram- negative bacteria, including 
enterobacteriaceae and others produce dozens of different β-lactamases 
enzymes interfere with the action of beta- lactam antibiotics (Forbes et al., 
1998). 
          The high antibiotic resistance showed by E.coli (92.1%) isolated in the 
present study from human and animal sources may be due to wide misuse of 
antibiotic in human and veterinary medicine. In addition antibacterial 
antibiotics may continuously used in foods of animals such as broiler as 
antimicrobial growth factor. 
                      
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUTIONS:  
          This study showed a high prevalence of antimicrobial drug resistance 
in E.coli isolated from different sources.    
          Infected poultry isolates showed the highest resistance to tetracycline 
(86%) and nalidixic acid (85%). 
          Women urine isolates showed high susceptibility to amikacin (100%), 
nitrofuranation (100%), gentamicin (75%).  
          Women urine isolates showed high resistance to tetracycline (75%).    
Medium susceptibility (50%) to ampicillin, most of the strains showed 
multi- resistance (87.8%). 
          Mastitic cow’s milk isolates were completely sensitive to amoxicillin 
(100%), ceftizoxime (100%), chloramphenicol (100%), cephalexin (100%), 
ciprofloxacine (100%), nitrofuranation (100%), nalidixic acid (100%), 
gentamicin (100%), norfloxacin (100%), ofloxacin (100%), ampicillin 
(100%), co- trimoxazole (100%) and pefoxacin (100%), but  showed high 
resistance to tetracycline (67%). 
          Child diarrhea isolates showed high resistance to amoxicillin (60%) 
and tetracycline (70%) and most of the strains showed multi- resistance 
85%.  
          All E.coli strains isolated in this study were resistant to one or more of 
beta- lactam antibiotics. 
          Multi- drug resistance was shown by most of the E.coli strains isolated 
in this study. 
           
 
 
RECOMMENDATION  
          From the results of this work it is recommended that: 
1- Further extensive work should be carried out to survey the prevalence 
of antibacterial drug- resistance to determine the most effective 
antibiotic. 
2- Further studies on antibacterial resistance, multi- resistant and plasmid 
profile should be conducted on E.coli isolates. 
3- More research should be carried out to examine genotypic 
relationships between human and animal E.coli isolates.  
4-     After examination of sensitivity of isolates, antibacterial drugs 
should be given in full therapeutic doses for adequate period.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
    
Ahmed, A.A.; Osman, H.; Mansour, H. A.; Mosa, H. A.; Ahmed, A. B.; 
Karrar, Z.; Hassan, H.S. (2000). Antimicrobial agent resistance in 
bacterial isolates from patients with diarrhea and urinary tract 
infection in the Sudan. AMJ. Trop. Med. Hyg., 631 (5-6): 259-263. 
Aiello, S. E. and Mays, A. (1998). The Merck Veterinary Manual 8th ed. 
Merck and co. Inc., White House station, N J, USA and Merial 
limited. 
Altom, K. H. (2000) Studies on colibacillus diarrhea in calves, sheep and 
goats. M. Sc. Thesis . University of Khartoum. 
Anonymous (1977). Coliform and Pseudomonas mastitis. Epidemiology         
and control. Vet. Res., 100: 441- 442.       
Atif, A. A.; Hani, O.; Alawayia, M. M.; Hassan, A. M.; Abdalla, B. A.;                                                            
          Zein, K. and Hassan, S. H. (2000) Antimicrobial agent resistanc in                             
          bacterial isolates from patients with diarrhea and urinary tract  
          infection in the Sudan. Am. J. Trop. Hyg., 63: 259- 263. 
Baker, F. J. and Breach, M. R. (1980). Medical Microbiology Tequniques. 
          Bultert worth and Co., (Publishers) Ltd., London.  
Bale, M.J.; Mclaws, S.M. and Fenn, J.P. (1984). Use of and cost savings      
          with morphologic criteria and the spot indole test as a routine means                             
          of identification of E.coli. Diag. Microbiol. Infect. Dis., 2: 187- 191.      
Barrow, I. G. and Feltham, K.A. (1993). Cowan and Steel’s Manual for       
          the Identification of Medical Bacteria. 3rd ed. Cambridge. U. Press 
 
 
Bass, L.; Liebert, C.; Lee, M.; Summers, A.; White, D.; Thayer, S.;      
          Maurer,J. (1999). Incidence and characterization of integrons,  
          genetic elements mediating multiple- drug resistance in Avian     
          Escherichia coli. Ant. Agen. Chemother., 43: 2925- 2929. 
Black, R. E. (1990). Epidemiology of traveler’s diarrhea and a relative 
importance of various pathogens. Rev. Infect. Dis., 1 (Supp- 1): 573- 
579. 
Blood, D.C.; Radositis, O.M.; Arundel, J.H. and Gay, C.C. (1990). Diseases 
caused by E.coli. In: Veterinary Medicine. 7th ed. Catham, PLC. 
Catham. Kenjt. Great Britain pp 619- 643. 
Bogaard, A. E.; London, N.; Driessen, C. and Stobberingh, E. E. (2000). 
          Antibiotic resistance of fecal Escherichia coli in poultry, poultry 
farms and poultry slaughters. J. Anti. Chemother., 47: 763- 771. 
Borstein, S. and Samberg, Y. C. (1953). Colibacillosis in geese caused       
          by Escherichia freundii. Pefnat. Veterinarith., 10: 95- 103.  
          Cited by Hofstad et al. (1978). 
Bray, J. (1945). Isolation of antigenically homogeneous strain of Bact. Coli 
Neapolitan from summer diarrhea of infants. J. Patho. Bacteriol., 57: 
239- 247. Cited by Greenberg, R.N. and Guerrant, R.L. (1981).  E.coli 
Heat- stable enterotoxin. Pharmacol. Ther., 33: 505- 531. 
Brenner, D.; Davis, B.; Sliegerwalt, A.; Riddle, C.; Macwhorter, A.; Allen, 
S.; Farnner, J.; Satah, Y., and Fanning, G. (1982). A typical Biogroups 
of E.coli found in clinical specimens and distribution of E. hermanii. 
SP.Nov. J. Clin. Microbial., 15: 703. 
Brody, T. M.; Larner, J.; Minneman, K. P. and Neu, H. C. (1994). Human  
pharmacology. 2nd ed. Mosby. Year Book. Inc. St. Louis. Missouri.           
Brunder, W.; Schmidt, H.; Frosch, M. and Karch, H. (1999). The large 
plasmids of shiga- toxin producing E.coli (EHEC) are highly variable 
genetic elements. Microbiology, 145: 1005- 1014. 
Brunder,W.; Schmidt, H. and Karch, H. (1997). Esp P. A novel Extracellular 
serine protease of EHEC cleaves human coagulation factor. Vet. 
Molec. Microbiol., 24: 767- 778. 
Buxton, A. and Frazer, G. (1977). Animal Microbiology, vol 1. 1st ed. Black  
          Well Scientific Publication. Oxford. London. Edinburgh and 
Melbourne. 
Carter, G. R. (1985). Essential of Veterinary Bacteriology and Mycology.  
          3rd ed. Lea and Febiger Philadelphia. 
Chauhan, R. S. and Kaushik, R.K. (1991). Isolation of enterotoxigenic 
Escherichia coli from camels with diarrhea. Vet. Microbiol., 29 (2): 
195- 197.  
Cheesbrough, M. (2000). District laboratory practice in tropical countries.  
         Part 2. Cambridge. 
Cheville, N. F. and Arp, L. H. (1978). Comparative pathological findings of  
E.coli infection in birds. J. Amer. Vet. Med. Ass., 173 (5): 584- 587. 
Chulasiri, M. and Suthienkul, O. (1989). Antimicrobial resistance of 
Escherichia coli isolated from chickens.   Vet. Microbiol., 21(2): 
          189- 194. 
Cid, D.; Piriz, S.; Ruiz, J. A.; Valle, J.; Vadillo, S.; de la Fuente, R. (1996). 
In vitro susceptibility of Escherichia coli strains isolated from 
diarrhoeic lambs and goat kids to 14 antimicrobial agents. J.Vet. 
Pharmacol. Ther., 19 (5): 397- 401. 
 
 
Cobeljic, M., Milkovic-Selimovic, B., Paunovic-Todosijevic, D. (1996)     
          Enteroaggregative Escherichia coli associated with an outbreak of             
          diarrhoea in a neonatal ward. Epidemiolo and Infect., 11(7):11-16. 
Cohen, M. L. (1992). Epidemiology of drug resistance: implications for  
          post- antimicrobial. Science, 257: 1050- 1055. 
Cruckshank, J. P.; Dugi, B. P.; Marmion, R. H. A. and Swain, B. (1975).  
          Medical Microbiology. Volume one. Microbial infection 12th ed.                                     
          Churchil Livingston, Edinburgh and London. 
David, G. W.; Charlene, H.; John, J. M.; Sherry, A.; Shaohua, Z.; Margie, D. 
L.; Lance, B.; Thomas, F. and Julie, S. (2000). Characterization of 
Chloramphenicol and Florfenicol resistance in Escherichia coli 
associated with bovine diarrhea. J. Clin. Microb., 38 (12): 4593- 4598. 
Davies, J. (1992). Another look at antibiotic resistance. J. of Gen.  
          Microbiol., 138: 1553- 1559. 
Davies, J. (1994). Inactivation of antibiotics and the dissemination of  
           resistance genes. Science, 264: 375- 382. 
De Brito, B. G.; Gaziri, L. C. and Vidotto, M. C. (2003). Virulence factors  
          and clonal relationship among Escherichia coli strains isolated from 
broiler chichens with cellulitis. Infect .Immun., 71(7): 4175-4177. 
Dimock, W. W.; Edwards, P. R. and Burener, D. W. (1947). Infections 
observed in equine fetuses and foals. Cornell Vet., 37: 89- 99. Cited 
by Gillespe and Timoney (1981). 
Elgadasi, SH. D. (2003). Identification of bacteria isolated from mastitic 
milk of cattle, sheep and goats in Khartoum State and study of 
antimicrobial. M. V. Sc. Thesis. University of Khartoum. 
El- Gasim, R. M. (1999). Plasmid profile of E.coli extracted from different 
sources (Human, Animal, and Water). M. Sc. Thesis. University of 
Khartoum. 
Ellaithi, S. (2004). Characterization of E.coli isolated from diarrhoeic calves 
in the Sudan. Ph. D. Thesis. University of Khartoum. 
El shekh, A. (2004). Bacterial associated with urinary tract infections in 
pregnant women.  M. Sc. Thesis . University of Khartoum. 
Ephros, M., Cohen, D., Yavzori, M., Rotman, N., Novics, B. and Ashkenazi, 
S. (1996). Encephalopathy associated with Enteroinvasive 
Escherichia coli O144:NM infection. J. Clin. Microbiol., 34:2432-
2434. 
Eslava, C.; Navarro, F. G.; Zezulin, J. R.; Henderson, I. R.; Cravioto, A. and 
Nataro, J. P. (1998). An outotransproter enterotoxin from entero 
Aggregative E.coli. Infect. Immun., 66: 3155- 3163. 
Ewers, C.; Janssen, T. and Wieler, L. H. (2003). Avian pathogenic 
Escherichia Coli. Berl .Munch .Tierarztl .Wochenschr., 116 (9-10): 
381- 395. 
Farmer, J. J.; Fanning, G. R.; Davis, B. R.; O’Hara, C. M.; Riddle, C.;  
          Hichman, F. W.; Asbury, M. A.; Lowery, V. A.and Brenner, D. J. 
(1985). Escherichia fergusonii and Enterobacter tylorae, two new 
species of Enterobacteriaceae isolated from clinical specimens. J. 
Clin. Microbiol., 21: 77-81. 
Fluit, A. D.; Visser, R. M.  and Franz, J. S. (2001). Molecular detection of 
          antimicrobial resistance. Clin. Microbiol. Rev., 14 (4): 836- 887. 
Forbes, B. A.; Sahm, D. F. and Wessfeld, A. S. (1998). Bailley and Scott’s. 
Diagnostic Microbiology. 10th  ed. Mosby, London.  
Frganis, O.; Kaya, O.; Corlu, M. and Istanbulluoglu, F. (1989). 
Hemagglutination, hydrophobicity, and enterotoxigenicty of E.coli. 
Avia. Dis., 33 (4): 631- 635. 
Gillespie, J. H.; and Timoney, J. F. (1981). The enterobacteriaceae. The                 
Lactose fermenters. In: Hagan and Bruners infectious diseases of  
          domestic animals. 7th ed. London WIY. IAA, U.K. Cornell                                                                               
          University Press. Ltd 2- 4 Brook Street. pp 74- 83. 
Giron, J. A.; Jones, T.; Millan-Velasco, F.; Castro-Munoz, E.; Zarate, L.;                   
          Fry, J.; Frankel, G.; Moseley, S. L.; Baudry, B. and Kaper, J. B.  
           (1991) Diffuse- adhering Escherichia coli (DAEC) as a putative  
          cause of diarrhea in Mayan children in Mexico. J. Infect. Dis.,  
          163:507-513     
Giron, J. A.; Ho, A. S. and Schootnik, G. K. (1991). An inducible bundle 
forming pilus of EPEC., Science, 254: 710- 713. 
Guerrant, R. L.; Moore, R. A.; Kirschenfe, D. and Sande, M. A. (1975). Role   
of toxigenic and invasive bacteria in acute diarrhea of 
childhood.N.Engl. J.Med., 293: 567- 573. 
Guyot, A.; Barrett, S. P.; Threlfall, E. J; Hampton, M. D. and Cheasty, T. 
(1999). Molecular epidemiology of multi- resistant Escherichia coli. 
J. Hosp. Infect., 43(1): 39- 48. 
Gyles, C.L. (1993). E.coli. In: Pathogenesis of Bacterial Infections in  
          Animals. Gyles, C.L. and Thoen C.O (eds). Lowa  State.  U. Press. 
USA. pp 164- 187. 
Hadad, J. J. and Gyles, C.L. (1982). Scaning and transmission electron  
          microscope study of the small intestine of colostrums- fed calves  
          infected with selected strains of E.coli. Am. J. Vet. Res., 43: 41- 49. 
Hagan and Brunners (1981). Microbiology of infectious diseases of 
domestic animals. 7th edition. London. WIY. IAA, U. K. Cornell 
University. Press Lted. 204 Brook Street. 
Heritage, J.; Evans, E. G. V. and Killington, R. A. (1996). Introductory 
          Microbiology. Great Britain. Cambridge. University Press. 
Holland, R. E. (1990). Some infectious causes of diarrhea in young farm  
          animals., Clin. Microbiol. Rev., 3: 345- 375. 
Howarth, J.A. (1932). B.coli like organism causing abortion in sheep. 
Cornel. Vet., 22: 253- 260. 
Hugo, W. B. and Russell, A. D. (1989). Pharmaceutical Microbiology. 4th         
ed. Oxford. London. Edinburgh. Butler and Tanner Ltd., Frome and 
London. 
Illyutovich, A.Y.; Petrova, Z. S.; Khoteeva, R. S.; Makhlinovsky, L. L.; 
Golubeva, E. E. and Raikis, B. N. (1962). The cat as an experimental 
model for studying colienteritis and its pathogenesis. J. Microbiol. 
Moskow., 33 (1): 83- 89.                 
Jacoby, G. A. and Archer, G. L. (1991). New Mechanisms of bacterial 
resistance to antimicrobial agents. New Eng. J. of Med., 324 (9): 601- 
612. 
James, R. J.; Michael, A. K.; Megan, M.; Abby, G. M.; and Javier, G.              
          (2006).  Similarity between Human and Chicken Escherichia coli  
          Isolates in Relation to Ciprofloxacin Resistance Status. J. Infect  
          Dis .194:71-78 
Jawetz, E.; Melnick, J. L.; Adelberg, E. A.; Brooks, G. F.; Butel, J. S. and 
Ornston, L. N. (1989). Medical Microbiology. 18th ed. Appleton and 
Longe. Norwalk, Connecticut/ Los Altos, California. 
John, G. H. (1984). Bergey’s Manual of Systemic Bacteriology: Gram- 
negative bacteria of general, medical, or industrial importance.1st  
edition. Volume 1. Williams and Wilkins, Blatimore.               
Johnson, J. R. (1991). Virulence factors in E.coli urinary tract infection.  
          Clin. Microbiol. Rev., 4: 80- 128. 
Jose, A. D.; Antonio, P. M.; Leonardo, D.M.; Ricardo, B. T.; Andre, A. D.; 
Adauto, J. C.; Edson, L. P.; Silvio, T. J. (2002). Community acquired 
urinary tract infection: etiology and bacterial susceptibility. Acta Cir. 
Bras., 18 (suppl-5): 20 
Kado, C. I. and Liu, S. T. (1981). Rapid procedure for detection and        
             isolation of large and small plasmids. J. Bacteriol., 145: 1365–1373. 
Kocks, C.; Marchand, J. D.; Couin, E.;DHuteville, H.; Sansonetti, P. J.;  
          Cortier, M. F. and Cossart, P. (1995). The unrelated surface proteins 
of L. monocytogenes and ICSA of S. feleneri are sufficient to confer 
actin- based motility on listeria and E.coli respectiviely., Mol. 
Microbiol., 18: 413- 423. 
Korhonen, T. K.; Valtonen, M. V.; Parkkinen, J.; Finne, J. and Orskov, F.  
          (1985). Serotypes, haemolysin production and receptor recognition of 
E.coli strain associated with neonatal sepsis and meningitis. Infect. 
          Immune., 48: 486- 491. 
Lia, L. C.; Wainwright, L. A.; Stone, K. D. and Donnenberg, M. S. (1997). 
A third secreted protein that is encoded by the enteropathogenic 
E.coli. Pathogenicity island is required for transduction of signals and 
for attaching and effacing activities in host cells. Infect. Immune., 65: 
2211- 2217. 
Lambert, H.P. (1979). Clinics in Gastroenterology. W.B. sauder. London.  
          Philadelphia . USA. 
Lancini, G.; Parenti, F. and Gallo, G. G. (1995). Antibiotic: A 
multidisciplinary approach. Plenum Publishing Corporation, New 
York. 
Leclerc, H. (1962). In: Cowan and Steel’s Manual for the identification of 
Medical Bacteria (1993). 3rd ed. Cambridge. U. Press. P 135. 
Levine, M. M. and Edelman, R. (1984). Enteropathogenic E.coli of classic 
Serotypes associated with infant diarrhea. Epidemiology and 
Pathogenesis. Epidemol.Rev., 6: 31- 51. 
Lindstedt, B. A.; Heir, E.; Vardund, T.; Kapperud, G. (2003). DNA  
          fingerprinting of shiga- toxin producing Escherichia coli 0157 based 
on multiple- locus variable. Number Tandem- Repeats Analysis 
(MLVA). Ann. Clin. Microbiol. Antimicrob., 2: 12. 
Lydia, B.; Cynthia, A. L.; Margie, D. l.; Anne, O. S.; David, G. W.; Stephan, 
G. T. and John, J. M. (1999). Incidence and characterization of 
integrons, genetic elements mediating multiple- drug resistance, in 
avian Escherichia coli. Antimicrobiol Agent Chemoth., 43 (12) 2925- 
2929. 
Macias, A. E.; Herrera, L. E.; Munoz, J. M.; Medina, H. (2002). Antibiotic  
resistant fecal Escherichia coli in healthy children. Induced by the use 
of antibiotics. Rev. Invest. Clin., 54 (2): 108- 112. 
Malkawi, H. I. and Youssef, M. T. (1998). Antibiotic susceptibility testing 
and plasmid profiles of Escherichia coli isolated from diarrhoeal 
patients. J. Trop. Pediatr., 44(3): 128- 132. 
Mansi, W. (1962). Advances in small animals practice. Newyork. Pergamon 
Press. 3: 29. 
 
Maurer,J. J.; Lee, M. D.; Lobsinger, C.; Brown, T.; Maier, M. and Thayer, S. 
G. (1998). Molecular typing of avian Escherichia coli isolates by 
Random amplification of polymorphic DNA. Avian Dis., 42 (3): 431-
451. 
Mc Dermott, P. F.; Robert D. W.; David G. W. (2003). Antimicrobials:          
          Modes of Action and Mechanisms of Resistance. Inter. J. Toxic., 22:  
          135 – 143. 
Mohamed, M. M. (2005). Susceptibility and resistance of Gram- positive 
and Gram- negative aerobic bacteria isolated from different sources in 
Khartoum State. M. Sc. Thesis . University of Khartoum. 
Moorthy, A. R. S. (1985). Isolation of E.coli from an aborted bovine fetus. 
Vet. Rec., 116(6): 159 
Muller, W. D. (1960). Bacterielle deckin faction in einer ziegenbockhaltung. 
Tierarztl. Umsch., 15: 406- 407. Cited by Sojka, W. J. (1965). 
Nagi, M. S. and Khanna, P. N. (1967). A cholera- like disease in chicken due 
to haemolytic E.coli. Indian. Vet. J., 44 (8): 629-633. 
Nemeth, J. (1987). A comparative study of virulence of bovine mastitis and 
fecal E.coli isolates. Ph.D diss. University of Guelph. Ontario. 
Neu, H. C. (1992). The crisis in antibiotics resistance. Science, 257: 1064-
1073. 
Newman, M. J. and Seidu, A. (2000).  Carriage of antimicrobial resistant 
Escherichia coli in adult intestinal flora. West Afr. J. Med., 21 (1): 
48- 50. 
 
 
Nocard, E. and Leclainche, E. (1898). Les- maladies- microbiennes des 
animaux. 2ed edition. Masson G. Paris. Pp 956. Cited by Greenberge, 
R.N. and Guerrant, R.L.(1981). E.coli heat- stable enterotoxin. 
Pharmacol. Ther., 13: 507- 531. 
Okeke, I.; Lamikanva, A.; Steinriich, H. and Kaper, J. (2000). 
Characterization of Escherichia coli strains from cases of childhood 
diarrhea in provincial southwestern Nigeria. J. Clin. Microbiol., 38: 7- 
12. 
Orden, J. A.; Ruiz, J. A.; Garcia, S.; Cid, D. and Fuente, R. (2000). In vitro 
susceptibility of Escherichia coli strains isolated from diarrhoeic diary 
calves to 15 antimicrobial agents. J. Vet. Med. B. Infect. Dis. Vet. 
Public Health., 47(5): 329- 335. 
Orskov, F., Orskov, I., Evans, D. J. (1974). Special E.coli serotypes among 
ETEC strains from diarrhea in adults and children. Med. 
Microbial.Immune., 162: 73- 80. 
Osmani, A. S.; Sinha, R. P.; Soman, J. P. (1992). Studies on bacteria isolated 
from enteric goats. Indian. J. of Vet. Med., 12 (1): 31- 32. 
Oxenford, C. G.; Lomas, G. R. and Love, D. N. (1984). Bacteriuria in the 
dog. Smal. Anim. Pract., 25: 83-91. 
Peiffer, I.; Servin, A. L. and Berret, C., M. F. (1998). Piracy of decay- 
accelerating factor (CDSS), signal transduction by the diffusely 
adhering E.coli 1845. Infect. Immun., 66: 4036- 4042. 
Pratt, W. B. and Tylor, P. (1990). Principles of drug action, The Basis of 
Pharmacology. 3rd ed. Churehill Livingstone. Inc. New York. 
Puente, J. L. and Finlay, B. B. (2001). Pathogenic E.coli. In: Principle of 
bacterial pathogen. Academic Press. pp 387- 429. 
 
Qadri, F. ; Svennerholm, A. M.; Faruque, A. S. and Sack, R. B. (2005).                            
          Enterotoxigenic Escherichia coli in developing countries:                
          epidemiology,      microbiology, clinical features, treatment, and  
          prevention. Clin Microbiol  Rev; 18(3):465-483. 
Quagliarello, V.; and Scheld, W. M. (1992). Bacterial meningitis 
pathogenisis. Pathophysiology and progress. New Engl. J. Med., 237: 
864- 872. 
Radostitis, O. M.; Blood, D. C. and Gay, C. C. (1994). Veterinary Medicine 
8th ed. Educational Low . Priced Books. Scheme (ELBS), Bailliere 
Tindal, London. 
Robertson, E.A. and Mc Clowry, J.D. (1974). Mathematical analysis of the  
API Enteric 20 profile register using a computer diagnostic 
model.Appl. Microbiol., 28 (4): 691- 695.    
Robins, J. B.; Mc Crackan Jr, G. H.; Gotschlich, E. C.; Orskov, I. and 
Hanson, L. A. (1974). E.coli KI capsular polysaccharide associated 
with neonatal meningitis. J. Med., 290: 1216- 1220. 
Rombli, B. (1942). Le Malattiedi allevamento nei camelidi. Sudan diuna 
enzoozia di natura coli- bacillare nei neonati mandria della R. ed.1. 
Tenuta di S. Rossori (Pisa). Enzootiv bacterium coli infection in 
newborn camels. Nuova. Vet., 20: 85- 93. Vet. Bull., 13: Abs. No. 
1044. 
Sack, R. B. (1975). Human diarrheal disease caused by ETEC. Ann. Rev. 
Microbiol., 29: 333- 353. 
Sack, R.B. (1981). Dignosis of E.coli infection. In: Acute enteric infection in 
children. Holme, T.; Hdmgren, J.,  Merson, M.H. and Mollby, R. 
(eds). Elsevier / North Holand, Biomed. Press. Pp 444- 459.          
Salle, A. J. (1971). Fundamental principles of bacteriology. 7th ed. United 
State of America. 
Salvadori, M. R.; Valadares, G. F.; Leite, D. D.; Blanco, J.; Yano, T. 
(2003).Virulence factors of Escherichia coli isolated from calves with 
diarrhea in Brazil. Braz. J. Microbial, 34 (3): 1517- 8382. 
Sasipreexyajan , J. and Pakpinyo, S. (1992). The result of using enrofloxacin  
in broiler chickens after experimental E.coli infection. Thai. J. Vet. 
Med., 22 (2): 95- 104. 
Senior, D. F.; De Man, P. and Svanborg, C. (1992). Serotype haemolysin in 
production and adherence characteristics of E.coli causing urinary 
tract infection in dogs. Americ J.  Vet. Res., 63 (4): 494- 498. 
Shears, P.; Hart, C. A.; Broadhead, R. L.; Coulter, J. B. (1987). A note on 
antibiotic resistance in Escherichia coli isolated from children with 
diarrhea in the Sudan. Ann. Trop. Paediatr., 7 (1): 38- 41. 
Smith, P. B.; Tomforrde, K. M.; Rhoden, D. L. and Balows, A. (1973). API 
System: Amultitude micro method for identification of 
enterobacteriaceae. Appl. Microbiol., 24(1): 58- 61. 
Soyletir, G. and Gunalp, A. (1985). Antibiotic susceptibility of E.coli strains 
isolated from urinary tract infections and the role of metabolically 
deficient strains in these infections. Microbiol. Bull., 19 (4): 210-217. 
Spratt, B. G. (1994). Resistance to antibiotics mediated by target         
alternations. Science, 264: 388- 393. 
Stapleton, A. (2003). Novel approaches to prevention of urinary tract          
infections., Infect. Dis. Clin. North Am., 17(2): 457- 471.        
 
 
Thomas, C. G. A. (1993). Medical microbiology. 6th ed. Baillira Tindal, 
London, Cambridge. 
Timms, I. M.; Marshall, P. N. and Breslin, M. F. (1989). Evaluation of the 
efficacy of chlortetracycline for the control of chronic respiratory 
disease caused by Escherichia coli and Mycoplasma gallisepticum. 
 Res. Vet. Sci., 47(3):377-382. 
Tortura, G.J.; Fenke, B.R. and Case, C.L. (1986). Microbiology An          
Introduction 2nd. The Bengamin/Cummings publishing company, Inc  
Walia, S. K.; Kaiser, A.; Parkash, M.; Chaudhry, G. R. (2004). Self- 
Transmissible antibiotic resistance to ampicillin, streptomycin and    
tetracycline found in Escherichia coli isolates from contaminated 
drinking water. J. Environ. Sci. Heal., 39 (3): 651- 662. 
Wilkie, I.W. (1981). Polyserositis and meningitis associated with 
Escherichia coli infection of piglets. Can. Vet. J., 22: 171- 173. 
 
